Year 4- module b- clinical placement

This study guide was developed by the Faculty of Medicine, Umm AlQura University 2018.

All copyrights are reserved. No part of this guide may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage

and retrieval system, without permission in writing from the Faculty Edited by:

”ǤŽƒƒ‘Œ‡†Ƭ”Ǥƒ‹ƒƒ‹‹

Table of content

’‘”–ƒ–…‘–ƒ…–•ǣǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤ͵

—‹†‡‹ǣǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤͶ

—–Ž‹‡‘ˆ‡ƒ”Ͷ‘ˆǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤͶ

–”‘†—…–‹‘ǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤͶ

‹‘ˆ‡ƒ”ͶǣǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤͶ

–”—…–—”‡‘ˆ‡ƒ”ͶǣǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤͷ

Ž‹‹…ƒŽŽƒ…‡‡–ǣǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤ͸

–—†‡–•Ž‹‹…ƒŽ”‹˜‹Ž‡‰‡•ǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤ͸

‘†—Ž‡Ž‹‹…ƒŽŽƒ…‡‡–ǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤ͹

‘†—Ž‡‘”‡Ž‹‹…ƒŽ”‡•‡–ƒ–‹‘•ǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤ͹

‘†—Ž‡‘”‡ƒ”†‹ƒ…‹•‡ƒ•‡•ǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤͺ

‘†—Ž‡‘”‡‡•’‹”ƒ–‘”›‹•‡ƒ•‡•ǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤͳ͵

‘†—Ž‡‘”‡†‘…”‹‘Ž‘‰›‹•‡ƒ•‡•ǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤͳͻ

‡ƒ”Ͷ‘”–ˆ‘Ž‹‘–‡•ˆ‘”‘†—Ž‡ǣǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤʹͶ

’’‡†‹š‡•ǣ˜ƒŽ—ƒ–‹‘ ‘”•ǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤʹͷ

Ž‹‹…ƒŽ˜ƒŽ—ƒ–‹‘š‡”…‹•‡ȋ‹‹ǦȌǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤʹͷ

ƒ•‡Ǧ„ƒ•‡†‹•…—••‹‘ȋȌǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤʹ͹

˜‹†‡…‡Ǧƒ•‡†”ƒ…–‹…‡ȋȌǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤ͵Ͳ

‡ƒ”Ͷ”‘…‡†—”‡•ƒ”†ǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤ͵ͳ

‡‘—•Š”‘„‘‡„‘Ž‹•ȋȌ’”‘Œ‡…–ǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤǤ͵ʹ

6 7

7 7

7 8

10 9

10 11

11 16

22 27

32 33

34 34

36 36

Important contacts:

Emails Names

Important Contacts No.

…Ž‹‹…ƒŽ’Žƒ…‡‡–—‹–̷‰ƒ‹ŽǤ…‘

Clinical Placement Unit 1.

†”—‰Žƒ̷‰ƒ‹ŽǤ…‘

Dr. Jihad Muglan Head of Clinical Placement Unit

2.

akrmonjed@uqu.edu.sa Dr. Alaa Monjed

Year 4 Lead

Vice Dean for Hospitals Affairs (females section)

3.

ashwarsi@yahoo.com Dr. Ashraf Warsi

Vice Dean for Hospitals Affairs (males section)

4.

UQUMED Year 4 Module B:

Cardiac, Respiratory, Endocrine and Diabetes presentations

Guide Aim:

Š‹•‰—‹†‡‘ˆ‡ƒ”Ͷ‘†—Ž‡Ž‹‹…ƒŽŽƒ…‡‡–‹•†‡•‹‰‡†ƒ•ƒ‘”‹‡–ƒ–‹‘’ƒ…ƒ‰‡ˆ‘”

•—’‡”˜‹•‹‰…Ž‹‹…ƒŽ–‡ƒ•ƒ–ƒˆˆ‹Ž‹ƒ–‡†Š‘•’‹–ƒŽ•ƒ†…Ž‹‹…ƒŽˆƒ…‹Ž‹–‹‡•Ǥ–’”‘˜‹†‡••–”—…–—”‡

ƒ†‘—–Ž‹‡‘ˆ‘†—Ž‡–”ƒ‹‹‰ǤŠ‹•‡ƒ„Ž‡•’ƒ”–‡”•‘ˆ•—’‡”˜‹•‹‰…Ž‹‹…ƒŽ–‡ƒ•ƒ†

–”ƒ‹‡”•–‘…‘–”‹„—–‡–‘…‘•–”—…–‹˜‡Ž›–‘students’ learning ‡š’‡”‹‡…‡•Ǥ

Outline of Year 4 of UQUMED MBBS

Introduction

‡ƒ” Ͷ ȋŽ‹‹…ƒŽ ”ƒ…–‹…‡ǦͳȌ ‘ˆ ’”‘‰”ƒ• „ƒ•‡† ‘ –Š‡ –Š‡‡ ‘ˆ

̶Integrated Clinical Care̶Ǥ‘”’Žƒ…‡Ǧ„ƒ•‡† Ž‡ƒ”‹‰ ‹• –Š‡ „ƒ…„‘‡ ‘ˆ ‡ƒ” Ͷ ƒ†

‘˜‹‰ –‘™ƒ”†• ‘”‡ ™‘”’Žƒ…‡Ǧ„ƒ•‡† Ž‡ƒ”‹‰ …ƒ „‡ ƒ …ŠƒŽŽ‡‰‹‰ –”ƒ•‹–‹‘ ˆ‘”

‡†‹…ƒŽ •–—†‡–•Ǥ‘ ƒ…Š‹‡˜‡ –Š‹•ǡ —…Š ‘ˆ –Š‡ Ž‡ƒ”‹‰ ™‹ŽŽ –ƒ‡ ’Žƒ…‡ ‹ Š‡ƒŽ–Š…ƒ”‡

•‡––‹‰•–‘‡•—”‡‡†‹…ƒŽ•–—†‡–•Šƒ˜‡‡š’‘•—”‡–‘’ƒ–‹‡–•™‹–Šƒ™‹†‡”ƒ‰‡‘ˆ

Š‡ƒŽ–Š…ƒ”‡ ‡‡†• ‹…Ž—†‹‰ ’”‹ƒ”› …ƒ”‡ ƒ† …‘—‹–› …ƒ”‡ ’”‡•‡–ƒ–‹‘•ǡ …Š”‘‹…

†‹•‡ƒ•‡ ƒƒ‰‡‡–ǡ ƒ…—–‡ ‹ŽŽ‡•• ’”‡•‡–ƒ–‹‘•ǡ ƒ† ’”‡Ȁ’‡”‹ ƒ† ’‘•–Ǧ‘’‡”ƒ–‹˜‡ …ƒ”‡Ǥ

‡ƒ”Ͷ‹•ƒŽ•‘ƒ–‹‡™Š‡•–—†‡–•™‹ŽŽ„‡„‘–ŠŽ‘‘‹‰„ƒ…™ƒ”†•ǣ–‘–Š‡‹”’ƒ•–Ž‡ƒ”‹‰ǡ

ƒ†—†‡”•–ƒ†‹‰Š‘™–Š‡‘”›ƒ†—†‡”•–ƒ†‹‰‘ˆŠ‡ƒŽ–Šƒ††‹•‡ƒ•‡Ž‹•–‘’”ƒ…–‹…‡Ǣ

ƒ† ˆ‘”™ƒ”†•ǣ —•‹‰ –Š‡ Ž‡ƒ”‹‰ ‹ –Š‹• ›‡ƒ” ƒ• ƒ ‡› ’ƒ”– ‘ˆ –Š‡ Œ‘—”‡› –‘ „‡…‘‡

…‘’‡–‡–‹–‡”•Ǥ Aim of Year 4:

Year 4 (Clinical Practice-1) aims to:

• †‡”•–ƒ†–Š‡‹–‡‰”ƒ–‡†ƒ’’”‘ƒ…Š–‘†‹ƒ‰‘•‹‰and managing patients’ problems.

• †‡”•–ƒ†–Š‡Š‡ƒŽ–Š…ƒ”‡•›•–‡ƒ†Š‘™’ƒ–‹‡–•ƒ……‡••…ƒ”‡Ǥ

• ‡ƒ”Š‘™–‘†‘…—‡–‹ˆ‘”ƒ–‹‘ƒ„‘—–’ƒ–‹‡–•ƒ†–Š‡‹”…ƒ”‡Ǥ Structure of Year 4:

Š‡ ƒ‹ •–”—…–—”‡ ‘ˆ ‡ƒ” Ͷ …‘•‹•–• ‘ˆ ˆ‘—”Horizontal ModulesǤ  ƒ††‹–‹‘ǡ –Š‡

Ž‘‰‹–—†‹ƒŽVertical Modules ‹–‡‰”ƒ–‡†™‹–Š–Š‡Š‘”‹œ‘–ƒŽ‘†—Ž‡•–Š”‘—‰Š‘—––Š‡›‡ƒ”

ƒ†‡š–‡†‹–‘–Š‡Žƒ–‡”›‡ƒ”•‘ˆ–Š‡’”‘‰”ƒǤ

• Module A:“Foundations of Clinical Practice” is an introduction and orientation module

†‡•‹‰‡†–‘ƒ••‹•–‹–Š‡–”ƒ•‹–‹‘‹–‘–‘™‘”’Žƒ…‡Ǧ„ƒ•‡†Ž‡ƒ”‹‰ǤŠ‹•‘†—Ž‡ƒŽ•‘

‹–”‘†—…‡• •–—†‡–• –‘ –Š‡ •–”—…–—”‡ ‘ˆ –Š‡ ›‡ƒ”ǡ Ž‡ƒ”‹‰ ‘’’‘”–—‹–‹‡•ǡ Š‘™ –‘

ƒš‹‹œ‡ ™‘”’Žƒ…‡Ǧ„ƒ•‡† Ž‡ƒ”‹‰ǡ ƒ† ‡˜ƒŽ—ƒ–‹‘ ‘ˆ ˆ‘”ƒ–‹˜‡ ƒ••‡••‡–

‘’’‘”–—‹–‹‡•Ǥ

• Module Bǣƒ”†‹ƒ…ǡ‡•’‹”ƒ–‘”›ǡ†‘…”‹‡ƒ†‹ƒ„‡–‡•’”‡•‡–ƒ–‹‘•ǤŠ‹•‹•„ƒ•‡†

‘‘”’Žƒ…‡Ǧ„ƒ•‡†Ž‡ƒ”‹‰ƒ’’”‘ƒ…ŠǤ

• Module Cǣ ‡—”‘Ž‘‰‹…ƒŽǡ ‹†‡›• ƒ† —”‹ƒ”› –”ƒ…–ǡ ‡ƒ–‘Ž‘‰‹…ƒŽ ƒ† ˆ‡…–‹‘—•

’”‡•‡–ƒ–‹‘•ǤŠ‹•‹•„ƒ•‡†‘‘”’Žƒ…‡Ǧ„ƒ•‡†Ž‡ƒ”‹‰ƒ’’”‘ƒ…ŠǤ

• Module D:ƒ•–”‘‹–‡•–‹ƒŽƒ†‡’ƒ–‘„‹Ž‹ƒ”›’”‡•‡–ƒ–‹‘•ǡ —†ƒ‡–ƒŽ•‘ˆ‡‡”ƒŽ

—”‰‡”›ǤŠ‹•‹•„ƒ•‡†‘‘”’Žƒ…‡Ǧ„ƒ•‡†Ž‡ƒ”‹‰ƒ’’”‘ƒ…ŠǤ

Š‡ Ž‘‰‹–—†‹ƒŽ ‡‹‰Š–Vertical Modules of “Pathological Sciences, Anatomy and Imaging, Use of Medicine, Clinical Skills, Research and Evidences, Family Health, Professional Development, and Hajj & Umrah”ƒ”‡‘‰‘‹‰–Š”‘—‰Š‘—––Š‡›‡ƒ”ƒ†‡š–‡†‹–‘–Š‡Žƒ–‡”

›‡ƒ”•‘ˆ–Š‡’”‘‰”ƒǤ

Š‡•–”—…–—”‡‘ˆ–Š‡’”‘‰”ƒ…‘—’Ž‡•Ž‡ƒ‹‰™‹–Šˆ‘”ƒ–‹˜‡ƒ••‡••‡–ƒ†…‘•–”—…–‹˜‡

ˆ‡‡†„ƒ…Ǥ –—†‡–• —•– ƒ‹–ƒ‹ ƒ† …‘’Ž‡–‡ ‘”’Žƒ…‡Ǧƒ•‡†Ǧ••‡••‡– –ƒ•• ƒ†

’”ƒ…–‹…ƒŽ’”‘…‡†—”‡•…ƒ”†ƒ•’ƒ”–‘ˆ–Š‡…‘’”‡Š‡•‹˜‡’‘”–ˆ‘Ž‹‘ǤŠ‡›ƒ”‡‡š’‡…–‡†–‘„‡

ƒ—–‘‘‘—•ƒ†•‡ŽˆǦ†‹”‡…–‡†Ž‡ƒ”‡”•Ǥ—ƒ–‹˜‡ƒ••‡••‡–•‹…Ž—†‡‡†‘ˆ–Š‡–‡”•

‡šƒ•ƒ†ˆ‹ƒŽ…‘’”‡Š‡•‹˜‡™”‹––‡ƒ†…Ž‹‹…ƒŽ‡šƒ•Ǥ

Clinical Placement:

Ž‹‹…ƒŽ ’Žƒ…‡‡–• ƒ”‡ –Š‡ •‡Ž‡–‘ ‘ˆ ›‡ƒ” Ͷ …—””‹…—Ž—Ǥ ‡ƒ”‹‰ ™‹ŽŽ „‡

ƒ…Š‹‡˜‡† „› ’Žƒ…‹‰ ›‡ƒ” Ͷ •–—†‡–• ‹ ƒ ”ƒ‰‡ ‘ˆ †‹ˆˆ‡”‡– …Ž‹‹…ƒŽ •‡––‹‰• ‹…Ž—†‹‰

‹’ƒ–‹‡–•ǡ‘—–’ƒ–‹‡–•†‡’ƒ”–‡–•ǡƒ†’”‹ƒ”›…ƒ”‡…‡–‡”•Ǥ Students Clinical Privileges

While on clinical placement, Year 4 students are expected to:

▪ ƒ‡Š‹•–‘”›ƒ†’‡”ˆ‘”’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘Ǥ

▪ •‡•‡’ƒ”ƒ–‡…Ž‡”‹‰‘–‡•–‘’”ƒ…–‹…‡…Ž‹‹…ƒŽ†‘…—‡–ƒ–‹‘ƒ†–Š‹••Š‘—Ž†‘–

be part of patient’s medical records and should not be stamped with patient’s IDǤ

▪ ……‡••–‘’ƒ’‡”Ǧ„ƒ•‡†ƒ†‡Ž‡…–”‘‹…medical records as “read only”Ǥ

▪ ‡˜‡”™”‹te in patients’ ‡†‹…ƒŽ”‡…‘”†•Ǥ

▪ ‡”ˆ‘”…‡”–ƒ‹…Ž‹‹…ƒŽ’”‘…‡†—”‡•—†‡”•—’‡”˜‹•‹‘•—…Šƒ•…ƒ—Žƒ–‹‘ƒ†

’ŠŽ‡„‘–‘›Ǥ

▪ Participate in hospital’s teaching activities.

Clinical Placement

“Any arrangement in which ƒ‡†‹…ƒŽ•–—†‡–‹•’”‡•‡–‹

ƒ‡˜‹”‘‡––Šƒ–’”‘˜‹†‡•Š‡ƒŽ–Š…ƒ”‡‘””‡Žƒ–‡†

•‡”˜‹…‡•–‘’ƒ–‹‡–•‘”–Š‡’—„Ž‹…ǤŽƒ…‡‡–•…ƒ–ƒ‡

’Žƒ…‡‹’”‹ƒ”›ǡ•‡…‘†ƒ”›‘”…‘—‹–›Š‡ƒŽ–Š…ƒ”‡‘”

•‘…‹ƒŽ…ƒ”‡•‡––‹‰•Ǥ–—†‡–•…ƒ„‡ƒ…–‹˜‡Ž›‹˜‘Ž˜‡†‹

’ƒ–‹‡–…ƒ”‡‘”–Š‡›…ƒ„‡‘„•‡”˜‹‰Š‡ƒŽ–Š‘”•‘…‹ƒŽ…ƒ”‡

processes”.

General Medical Council, UK

Module B Clinical Placement

▪ ‘†—Ž‡ …Ž‹‹…ƒŽ ’Žƒ…‡‡–• ƒ”‡ …‘†—…–‡† ‹ ƒ”†‹‘Ž‘‰›ǡ —Ž‘‘Ž‘‰›ǡ ƒ†

†‘…”‹‡‹–•‹ͷǦ͸†‹ˆˆ‡”‡–Š‘•’‹–ƒŽ•ƒ•™‡ŽŽƒ•’”‹ƒ”›Š‡ƒŽ–Š…ƒ”‡…‡–‡”•Ǥ

▪ –—†‡–• ”‘–ƒ–‡ ‹ …Ž‹‹…ƒŽ ’Žƒ…‡‡–• ‡˜‡”› ™‡‡• ȋˆ‘—”Ǧ†ƒ› ƒ ™‡‡ȌǤ Š‹•

‹…Ž—†‡•ƒ…ƒ†‡‹…ŠƒŽˆǦ†ƒ›ǣƒˆƒ…—Ž–›•–ƒˆˆ™‹ŽŽƒ””ƒ‰‡ƒ•–”—…–—”‡†…Ž‹‹…ƒŽ

–‡ƒ…Š‹‰ȋ‰”ƒ†”‘—†ǡ„‡†•‹†‡–‡ƒ…Š‹‰ǡ…ƒ•‡Ǧbased learning, …etc).

▪ ƒ…Š™‡‡–Š‡ˆ‹ˆ–Š†ƒ›™‹ŽŽ„‡•’‡†‹–Š‡ ƒ…—Ž–›ˆ‘”‡”–‹…ƒŽ‘†—Ž‡•–‡ƒ…Š‹‰Ǥ During Cardiology placements:

▪ –—†‡–•ƒ”‡‡š’‡…–‡†–‘•’‡†–‹‡‹‹’ƒ–‹‡–•ˆŽ‘‘”ȋ…ƒ”†‹ƒ…‹’ƒ–‹‡–•ƒ†Ȍǡ …ƒ”†‹‘Ž‘‰› ‘—–’ƒ–‹‡– …Ž‹‹…•ǡ …Ž‹‹…•ǡ •–”‡•• –‡•– …Ž‹‹…• ƒ† ΪȀǦ …ƒ–Š Žƒ„ ȋƒ•

ƒ’’”‘’”‹ƒ–‡ȌǤ

During Pulmonology placements:

▪ –—†‡–•ƒ”‡‡š’‡…–‡†–‘•’‡†–‹‡‹‹’ƒ–‹‡–•ˆŽ‘‘”ǡ’—Ž‘‘Ž‘‰›‘—–’ƒ–‹‡–…Ž‹‹…•ǡ

ƒ•–Šƒ…Ž‹‹…•ǡƒ†’—Ž‘ƒ”›ˆ—…–‹‘–‡•–…Ž‹‹…•ȋ™Š‡”‡ƒ˜ƒ‹Žƒ„Ž‡ȌǤ During Endocrinology placements:

▪ –—†‡–• ƒ”‡ ‡š’‡…–‡† –‘ •’‡† –‹‡ ‹ †‹ƒ„‡–‡• ƒ† ‡†‘…”‹‡ ‘—–’ƒ–‹‡– …Ž‹‹…•ǡ

†‹ƒ„‡–‹…‡†—…ƒ–‘”…Ž‹‹…ǡƒ†ˆ‘‘–Ǧ…ƒ”‡…Ž‹‹…ȋƒ•ƒ’’”‘’”‹ƒ–‡ȌǤŠ‡›ƒ”‡ƒŽ•‘‡š’‡…–‡†

–‘™‘”™‹–Š–Š‡‡†‘…”‹‡…‘•—Ž––‡ƒǡ™Š‡ˆ‡ƒ•‹„Ž‡Ǥ Module B Core Clinical Presentations

Ž‘‘†’”‡••—”‡…Šƒ‰‡• ‘••‘ˆ…‘•…‹‘—•‡••

Š‡•–’ƒ‹ ‡…•™‡ŽŽ‹‰

‘—‰Š „‡•‹–›

‘—‰Š‹‰—’„Ž‘‘† ƒŽ’‹–ƒ–‹‘•

ƒ›–‹‡•Ž‡‡’‹‡•• ‹”‡†ƒŽŽ–Š‡–‹‡

‹ˆˆ‹…—Ž–›„”‡ƒ–Š‹‰ ‡‹‰Š–Ž‘••

‡˜‡” Š‡‡œ‡

‡‰•™‡ŽŽ‹‰

Module B Core Cardiac Diseases

Hypertension

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›ˆ”‘ƒ’ƒ–‹‡–™‹–ŠŠ›’‡”–‡•‹‘Ǥ

ʹǤ ‡”ˆ‘”ƒ…‘’Ž‡–‡•›•–‡ƒ–‹…’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘‘ˆƒ’ƒ–‹‡–™‹–Š

Š›’‡”–‡•‹‘Ǥ

͵Ǥ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡…Ž‹‹…ƒŽƒ’’”‘ƒ…Š–‘ƒŠ›’‡”–‡•‹˜‡’ƒ–‹‡–ǣ

▪ ‘ˆ‹”‹‰–Š‡†‹ƒ‰‘•‹•‘ˆŠ›’‡”–‡•‹‘

▪ †‡–‹ˆ›‹‰–Š‡”‡†ˆŽƒ‰•‘ˆ•‡…‘†ƒ”›Š›’‡”–‡•‹‘

▪ Š‘‘•‹‰–Š‡ƒ’’”‘’”‹ƒ–‡•…”‡‡‹‰ƒ†…‘ˆ‹”ƒ–‘”›–‡•–•ˆ‘”•‡…‘†ƒ”›

Š›’‡”–‡•‹‘

▪ ••‡••‹‰–Š‡…‘–”‘Ž‘ˆŠ›’‡”–‡•‹‘

ͶǤ ‡…‘‰‹œ‡–Š‡…‘’Ž‹…ƒ–‹‘•‘ˆŠ›’‡”–‡•‹‘Ǥ

ͷǤ Recognize the blood pressure target for control for different patients’

’‘’—Žƒ–‹‘•Ǥ

͸Ǥ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”Š›’‡”–‡•‹‘ǡ‹…Ž—†‹‰‘Ǧ

’Šƒ”ƒ…‘Ž‘‰‹…ƒŽƒ†’Šƒ”ƒ…‘Ž‘‰‹…ƒŽƒƒ‰‡‡––ƒ‹‰‹–‘…‘•‹†‡”ƒ–‹‘

–Š‡…Ž‹‹…ƒŽ‹†‹…ƒ–‹‘•ǡ…‘–”ƒ‹†‹…ƒ–‹‘•ǡƒ†•‹†‡‡ˆˆ‡…–•‘ˆ‡ƒ…Š†”—‰…ƒ–‡‰‘”›Ǥ

͹Ǥ ‡˜‡Ž‘’ƒƒ’’”‘ƒ…Š–‘†‹ƒ‰‘•‡ƒ†‹‹–‹ƒ–‡–Š‡ƒƒ‰‡‡–‘ˆ

Š›’‡”–‡•‹˜‡‡‡”‰‡…›Ǥ

ͺǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–’s‡†—…ƒ–‹‘Ǥ

Ischemic heart disease

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒŠ‹•–‘”›ˆ”‘ƒ’ƒ–‹‡–™‹–Š…Š‡•–’ƒ‹ǡ†‹ˆˆ‡”‡–‹ƒ–‹‰„‡–™‡‡…ƒ”†‹ƒ…ƒ†

‘Ǧ…ƒ”†‹ƒ……Š‡•–’ƒ‹Ǥ

ʹǤ ‡”ˆ‘”ƒˆ‘…—•‡†’Š›•‹…ƒŽ‡šƒ‹ƒ’ƒ–‹‡–™‹–Š…Š‡•–’ƒ‹Ǥ

͵Ǥ ‘”—Žƒ–‡ƒ†’”‹‘”‹–‹œ‡ƒ†‹ˆˆ‡”‡–‹ƒŽ†‹ƒ‰‘•‹•‘ˆ…Š‡•–’ƒ‹

ͶǤ ‡•…”‹„‡–›’‡•‘ˆ‹•…Š‡‹…‡’‹•‘†‡•ȋ…Š”‘‹…•–ƒ„Ž‡ƒ‰‹ƒǡ•‹Ž‡–‹•…Š‡‹ƒǡ˜ƒ”‹ƒ–

ƒ‰‹ƒǡƒ…—–‡…‘”‘ƒ”›•›†”‘‡Ǣ•–ƒ„Ž‡ƒ‰‹ƒǡ‡Ž‡˜ƒ–‹‘›‘…ƒ”†‹ƒŽ‹ˆƒ”…–‹‘ǡ

‘Ǧ‡Ž‡˜ƒ–‹‘›‘…ƒ”†‹ƒŽ‹ˆƒ”…–‹‘Ȍ

ͷǤ ‡…‘‰‹œ‡–Š‡†‹ˆˆ‡”‡–†‹ƒ‰‘•–‹…‘†ƒŽ‹–‹‡•—•‡†‹–Š‡†‹ƒ‰‘•‹•‘ˆ‹•…Š‡‹…Š‡ƒ”–

†‹•‡ƒ•‡ƒ†–Š‡‹”ƒ‹‹†‹…ƒ–‹‘•ȋ•–”‡••ǡ”ƒ†‹‘—…Ž‹†‡›‘…ƒ”†‹ƒŽ’‡”ˆ—•‹‘

‹ƒ‰‹‰ǡ•–”‡••‡…Š‘ǡ…‘”‘ƒ”›…‘’—–‡†–‘‘‰”ƒ’Š›ǡŽ‡ˆ–Š‡ƒ”–…ƒ–Š‡–‡”‹œƒ–‹‘ƒ†

…‘”‘ƒ”›ƒ‰‹‘‰”ƒ’Š›ȌǤ

͸Ǥ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡‹˜‡•–‹‰ƒ–‹‘•–‘†‹ƒ‰‘•‡‹•…Š‡‹…Š‡ƒ”–†‹•‡ƒ•‡„ƒ•‡†

‘–Š‡ƒ˜ƒ‹Žƒ„Ž‡…Ž‹‹…ƒŽ†ƒ–ƒǤ

͹Ǥ –‡”’”‡–

▪ ‹•…Š‡‹……Šƒ‰‡•

▪ ƒ”†‹ƒ…„‹‘ƒ”‡”•

ͺǤ —–Ž‹‡–Š‡–Š‡”ƒ’›‘ˆƒ…—–‡…‘”‘ƒ”›•›†”‘‡…‘–”ƒ•–‹‰–Š‡†‹ˆˆ‡”‡…‡„‡–™‡‡

ƒƒ‰‡‡–‘ˆǡǡƒ†—•–ƒ„Ž‡ƒ‰‹ƒǤ

ͻǤ †‡–‹ˆ›–Š‡…‘’Ž‹…ƒ–‹‘•ƒ••‘…‹ƒ–‡†™‹–Š›‘…ƒ”†‹ƒŽ‹ˆƒ”…–‹‘Ǥ

ͳͲǤ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”…Š”‘‹…•–ƒ„Ž‡ƒ‰‹ƒ‹…Ž—†‹‰‘Ǧ

’Šƒ”ƒ…‘Ž‘‰‹…ƒŽƒ†’Šƒ”ƒ…‘Ž‘‰‹…ƒŽƒƒ‰‡‡––ƒ‹‰‹–‘…‘•‹†‡”ƒ–‹‘

‹†‹…ƒ–‹‘•ǡ…‘–”ƒ‹†‹…ƒ–‹‘•ǡ•‹†‡‡ˆˆ‡…–•ƒ†…‘’Ž‹…ƒ–‹‘•‘ˆ‡ƒ…Š…ƒ–‡‰‘”›Ǥ ͳͳǤ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”ƒ…—–‡…‘”‘ƒ”›•›†”‘‡‹…Ž—†‹‰

–Š‡‘Ǧ’Šƒ”ƒ…‘Ž‘‰‹…ƒŽƒ†’Šƒ”ƒ…‘Ž‘‰‹…ƒŽƒƒ‰‡‡––ƒ‹‰‹–‘…‘•‹†‡”ƒ–‹‘

‹†‹…ƒ–‹‘•ǡ…‘–”ƒ‹†‹…ƒ–‹‘•ǡƒ†•‹†‡‡ˆˆ‡…–•‘ˆ‡ƒ…Š…ƒ–‡‰‘”›Ǥ ͳʹǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–’s‡†—…ƒ–‹‘Ǥ

Heart Failure

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡Š‹•–‘”›‘ˆ’ƒ–‹‡–™‹–Š•Š‘”–‡••‘ˆ„”‡ƒ–Šƒ†Ȁ‘”Ž‘™‡”Ž‹„

•™‡ŽŽ‹‰Ǥ

ʹǤ ‡”ˆ‘”ƒˆ‘…—•‡†’Š›•‹…ƒŽ‡šƒ‹ƒ’ƒ–‹‡–™‹–Š•Š‘”–‡••‘ˆ„”‡ƒ–ŠǤ

͵Ǥ ‡”ˆ‘”ƒ…‘’”‡Š‡•‹˜‡’Š›•‹…ƒŽ‡šƒ‹ƒ’ƒ–‹‡–™‹–ŠŠ‡ƒ”–ˆƒ‹Ž—”‡Ǥ ͶǤ †‡–‹ˆ›–Š‡…Ž‹‹…ƒŽˆ‡ƒ–—”‡•‘ˆŠ‡ƒ”–ˆƒ‹Ž—”‡Ǥ

ͷǤ Žƒ••‹ˆ›Š‡ƒ”–ˆƒ‹Ž—”‡„ƒ•‡†‘–Š‡

ƒǤ Ejection fraction ȋ‡ƒ”– ƒ‹Ž—”‡™‹–Š’”‡•‡”˜‡†‡Œ‡…–‹‘ˆ”ƒ…–‹‘ ’ ǡ‡ƒ”–

ƒ‹Ž—”‡™‹–Š‹†”ƒ‰‡‡Œ‡…–‹‘ˆ”ƒ…–‹‘ ” ǡ‘”‡ƒ”–ˆƒ‹Ž—”‡™‹–Š”‡†—…‡†

‡Œ‡…–‹‘ˆ”ƒ…–‹‘ ” Ȍ b. Etiological abnormalities

c. New York Heart Association NYHA functional classification

͸Ǥ ‡…‘‰‹œ‡–Š‡†‹ˆˆ‡”‡–†‹ƒ‰‘•–‹…‘†ƒŽ‹–‹‡•—•‡†‹–Š‡†‹ƒ‰‘•‹•‘ˆŠ‡ƒ”–ˆƒ‹Ž—”‡Ǥ

͹Ǥ ‘•–”—…–ƒ†‹ƒ‰‘•–‹…ƒ’’”‘ƒ…Š–‘Š‡ƒ”–ˆƒ‹Ž—”‡„ƒ•‡†‘‡–‹‘Ž‘‰›ǡ•›’–‘•ƒ†

‹˜‡•–‹‰ƒ–‹‘ȋǡ…Š‘ǡ…ƒ”†‹ƒ……ƒ–Š‡–‡”‹œƒ–‹‘ȌǤ ͺǤ –‡”’”‡–ˆ‹†‹‰•ƒ••‘…‹ƒ–‡†™‹–ŠŠ‡ƒ”–ˆƒ‹Ž—”‡Ǥ

ͻǤ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”…Š”‘‹…Š‡ƒ”–ˆƒ‹Ž—”‡‹…Ž—†‹‰–Š‡

‘Ǧ’Šƒ”ƒ…‘Ž‘‰‹…ƒŽƒ†’Šƒ”ƒ…‘Ž‘‰‹…ƒŽƒƒ‰‡‡––ƒ‹‰‹–‘…‘•‹†‡”ƒ–‹‘

‹†‹…ƒ–‹‘•ǡ…‘–”ƒ‹†‹…ƒ–‹‘•ǡƒ†•‹†‡‡ˆˆ‡…–•‘ˆ‡ƒ…Š…ƒ–‡‰‘”›Ǥ ͳͲǤ ‘–”ƒ•––Š‡†‹ˆˆ‡”‡–ƒƒ‰‡‡–•–”ƒ–‡‰‹‡•ˆ‘” ”ˆƒ† ’ Ǥ ͳͳǤ ‘•–”—…–ƒƒ’’”‘ƒ…Š–‘–Š‡ƒƒ‰‡‡–‘ˆƒ…—–‡’—Ž‘ƒ”›‡†‡ƒǤ ͳʹǤ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Pericardial Diseases

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒƒ……—”ƒ–‡ƒ†…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›‘ˆ’‡”‹…ƒ”†‹–‹•Ȁ’‡”‹…ƒ”†‹ƒŽ

‡ˆˆ—•‹‘Ǥ

ʹǤ ‡”ˆ‘”ƒ’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘ˆ‘”’‡”‹…ƒ”†‹–‹•Ǥ

͵Ǥ šƒ‹‡ˆ‘”•‹‰•‘ˆ’‡”‹…ƒ”†‹ƒŽ‡ˆˆ—•‹‘Ȁ–ƒ’‘ƒ†‡Ǥ ͶǤ †‡–‹ˆ›–Š‡‡–‹‘Ž‘‰›‘ˆƒ…—–‡ƒ†…‘•–”‹…–‹˜‡’‡”‹…ƒ”†‹–‹•Ǥ ͷǤ †‡–‹ˆ›–Š‡‡–‹‘Ž‘‰›‘ˆ’‡”‹…ƒ”†‹ƒŽ‡ˆˆ—•‹‘Ȁ–ƒ’‘ƒ†‡Ǥ

͸Ǥ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡‹˜‡•–‹‰ƒ–‹‘•–‘†‹ƒ‰‘•‡ƒ…—–‡ƒ†…‘•–”‹…–‹˜‡

’‡”‹…ƒ”†‹–‹•ȋƒ†‹ƒ‰‹‰ȌǤ

͹Ǥ –‡”’”‡––Š‡”‡•—Ž–•‘ˆ

▪ ‘ˆƒ…—–‡’‡”‹…ƒ”†‹–‹•

▪ ƒ‰‹‰ǣƒ†•…ƒ

ͺǤ ‡˜‡Ž‘’‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”ƒ…—–‡’‡”‹…ƒ”†‹–‹•Ǥ ͻǤ —–Ž‹‡–”‡ƒ–‡–‘ˆ’‡”‹…ƒ”†‹ƒŽ‡ˆˆ—•‹‘Ȁ–ƒ’‘ƒ†‡Ǥ

ͳͲǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Aortic Dissection

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒƒ……—”ƒ–‡ƒ†…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›‘ˆƒ‘”–‹…†‹••‡…–‹‘‘”

ƒ‡—”›•Ǥ

ʹǤ ‡”ˆ‘”ƒ’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘ˆ‘”ƒ‘”–‹…†‹••‡…–‹‘‘”ƒ‡—”›•Ǥ

͵Ǥ †‡–‹ˆ›–Š‡’”‡†‹•’‘•‹‰ˆƒ…–‘”•‘ˆƒ‘”–‹…†‹••‡…–‹‘Ǥ ͶǤ ‡•…”‹„‡…Ž‹‹…ƒŽˆ‡ƒ–—”‡•‘ˆƒ‘”–‹…†‹••‡…–‹‘Ǥ ͷǤ †‡–‹ˆ›–›’‡•ƒ†‡–‹‘Ž‘‰›‘ˆƒ‘”–‹…ƒ‡—”›•Ǥ

͸Ǥ —–Ž‹‡–”‡ƒ–‡–‘ˆƒ‘”–‹…†‹••‡…–‹‘Ǥ

͹Ǥ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Valvular Heart Disease

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡Š‹•–‘”›‘ˆ’ƒ–‹‡–™‹–Š˜ƒ˜—Žƒ”Š‡ƒ”–†‹•‡ƒ•‡‘”

‹ˆ‡…–‹˜‡‡†‘…ƒ”†‹–‹•Ǥ

ʹǤ Ž‹…‹–ƒ†‹–‡”’”‡––Š‡’Š›•‹…ƒŽ•‹‰•‘ˆƒ‘”–‹…•–‡‘•‹•ǡƒ‘”–‹…”‡‰—”‰‹–ƒ–‹‘ǡ

‹–”ƒŽ•–‡‘•‹•ǡ‹–”ƒŽ”‡‰—”‰‹–ƒ–‹‘ǡƒ†–”‹…—•’‹†”‡‰—”‰‹–ƒ–‹‘Ǥ

͵Ǥ Ž‹…‹–ƒ†‹–‡”’”‡––Š‡’Š›•‹…ƒŽ•‹‰•‘ˆ‹ˆ‡…–‹˜‡‡†‘…ƒ”†‹–‹•Ǥ ͶǤ †‡–‹ˆ›–Š‡”‹•ˆƒ…–‘”•‘ˆ‹ˆ‡…–‹˜‡‡†‘…ƒ”†‹–‹•Ǥ

ͷǤ †‡–‹ˆ›–Š‡‘•–…‘‘‘”‰ƒ‹••…ƒ—•‹‰‹ˆ‡…–‹˜‡‡†‘…ƒ”†‹–‹•Ǥ

͸Ǥ ‡˜‡Ž‘’ƒ†‹ƒ‰‘•–‹…ƒ’’”‘ƒ…Š–‘‹ˆ‡…–‹˜‡‡†‘…ƒ”†‹–‹•—•‹‰‘†‹ˆ‹‡†

Duke’s criteria.

͹Ǥ —–Ž‹‡–Š‡’”‹…‹’Ž‡•‘ˆƒƒ‰‡‡–‘ˆ‹ˆ‡…–‹˜‡‡†‘…ƒ”†‹–‹•Ǥ

ͺǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡†‹ƒ‰‘•–‹…ƒ’’”‘ƒ…Š–‘ƒƒ„‘”ƒŽ•›•–‘Ž‹…

ƒ†Ȁ‘”†‹ƒ•–‘Ž‹…—”—”Ǥ

Arrhythmia

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡Š‹•–‘”›ˆ”‘ƒ’ƒ–‹‡–™‹–Š’ƒŽ’‹–ƒ–‹‘‘”•›…‘’‡Ǥ

ʹǤ ‡”ˆ‘”ƒˆ‘…—•‡†’Š›•‹…ƒŽ‡šƒ‘ƒ’ƒ–‹‡–™‹–Š’ƒŽ’‹–ƒ–‹‘‘”•›…‘’‡Ǥ

͵Ǥ ‡•…”‹„‡‡–‹‘Ž‘‰›ǡ…Ž‹‹…ƒŽˆ‡ƒ–—”‡•ǡƒ†Ǧˆ‹†‹‰•‘ˆƒ–”‹ƒŽˆ‹„”‹ŽŽƒ–‹‘Ǥ ͶǤ ‡•…”‹„‡‡–‹‘Ž‘‰›ǡ…Ž‹‹…ƒŽˆ‡ƒ–—”‡•ǡƒ†Ǧˆ‹†‹‰•‘ˆ˜‡–”‹…—Žƒ”–ƒ…Š›…ƒ”†‹ƒǤ ͷǤ ‡…‘‰‹œ‡–Š‡…Ž‹‹…ƒŽ’”‡•‡–ƒ–‹‘‘ˆ„”ƒ†›…ƒ”†‹ƒǤ

͸Ǥ —–Ž‹‡„ƒ•‹…ƒƒ‰‡‡–’”‹…‹’Ž‡•‘ˆ„”ƒ†›…ƒ”†‹ƒƒ†–ƒ…Š›…ƒ”†‹ƒǤ

͹Ǥ ‘•–”—…–ƒƒ’’”‘’”‹ƒ–‡ƒ’’”‘ƒ…Š–‘ƒ••‡••ƒ’ƒ–‹‡–™‹–Š’ƒŽ’‹–ƒ–‹‘Ǥ ͺǤ ‹ˆˆ‡”‡–‹ƒ–‡„‡–™‡‡†‹ˆˆ‡”‡––›’‡•‘ˆ„Ž‘…•‘Ǥ

Module B Core Respiratory Diseases

Bronchial Asthma

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒˆ‘…—•‡†Š‹•–‘”›–‘’ƒ–‹‡–•™‹–Š•Š‘”–‡••‘ˆ„”‡ƒ–ŠȀƒ•–ŠƒǤ

ʹǤ ‡”ˆ‘”ƒƒˆ‘…—•‡†’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘–‘ƒ••‡••ƒ•–Šƒ•‡˜‡”‹–›Ǥ

͵Ǥ †‡–‹ˆ›ƒ•–Šƒ–”‹‰‰‡”•Ǥ

ͶǤ š’Žƒ‹–Š‡†‹ƒ‰‘•–‹……”‹–‡”‹ƒ‘ˆƒ•–ŠƒǤ ͷǤ Žƒ••‹ˆ›ƒ•–Šƒ•‡˜‡”‹–›Ǥ

͸Ǥ †‡–‹ˆ›–Š‡”‡†ˆŽƒ‰•›’–‘•ƒ†•‹‰•‘ˆ•‡˜‡”‡ƒ•–Šƒ‡šƒ…‡”„ƒ–‹‘Ǥ

͹Ǥ ‡…‘‰‹œ‡ƒ†‹••‹‘…”‹–‡”‹ƒˆ‘”ƒ•–ŠƒˆŽƒ”‡‘”‡šƒ…‡”„ƒ–‹‘Ǥ

ͺǤ †‡–‹ˆ›ˆƒ…–‘”•‹’ƒ…–‹‰‘ƒ•–Šƒ…‘–”‘Žȋ‡Ǥ‰ǡ˜‹”‘‡–ƒŽˆƒ…–‘”•ǡ‹ŠƒŽ‡”

–‡…Š‹“—‡ȌǤ

ͻǤ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡‹˜‡•–‹‰ƒ–‹‘•–‘†‹ƒ‰‘•‡ƒ•–Šƒƒ†ƒ••‡••

•‡˜‡”‹–›ȋ„Ž‘‘†–‡•–•ǡ‹ƒ‰‹‰ǡ•’‹”‘‡–‡”ȌǤ ͳͲǤ –‡”’”‡––Š‡”‡•—Ž–•‘ˆ

▪ ’‹”‘‡–‡”›

▪ ”–‡”‹ƒŽ„Ž‘‘†‰ƒ•‡•

▪ ƒ‰‹‰

ͳͳǤ ‘”—Žƒ–‡ƒ†’”‹‘”‹–‹œ‡ƒ†‹ˆˆ‡”‡–‹ƒŽ†‹ƒ‰‘•‹•ˆ‘”•Š‘”–‡••‘ˆ„”‡ƒ–ŠǤ ͳʹǤ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”ƒ•–ŠƒǤ

ͳ͵Ǥ ••‡••”‡•’‘•‡–‘–”‡ƒ–‡–Ǥ

ͳͶǤ’’”‘’”‹ƒ–‡Ž›’”‹‘”‹–‹œ‡”‡ˆ‡””ƒŽ–‘”‡•’‹”ƒ–‘”›…Ž‹‹…Ǥ ͳͷǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Chronic Obstructive Pulmonary Disease (COPD)

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›ˆ”‘’ƒ–‹‡–•™‹–Š•–ƒ„Ž‡Ǥ

ʹǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›‘ˆ’ƒ–‹‡–•™‹–Šƒƒ…—–‡‡šƒ…‡”„ƒ–‹‘‘ˆ

Ǥ

͵Ǥ ‡”ˆ‘”ƒ…‘’Ž‡–‡•›•–‡ƒ–‹…’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘‘ˆƒ’ƒ–‹‡–™‹–Š•–ƒ„Ž‡

Ǥ

ͶǤ ‡”ˆ‘”ƒ…‘’Ž‡–‡•›•–‡ƒ–‹…’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘‘ˆ’ƒ–‹‡–™‹–Šƒƒ…—–‡

‡šƒ…‡”„ƒ–‹‘‘ˆǤ ͷǤ Žƒ••‹ˆ›•‡˜‡”‹–›Ǥ

͸Ǥ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡–‡•–•Ȁ‹ƒ‰‹‰–‘ƒ••‡••’ƒ–‹‡–•™‹–ŠǤ

͹Ǥ –‡”’”‡––Š‡”‡•—Ž–•‘ˆ

▪ ’‹”‘‡–‡”›

▪ ”–‡”‹ƒŽ„Ž‘‘†‰ƒ•‡•

▪ ƒ‰‹‰

ͺǤ ‘”—Žƒ–‡ƒ†’”‹‘”‹–‹œ‡ƒ†‹ˆˆ‡”‡–‹ƒŽ†‹ƒ‰‘•‹•ˆ‘”•Š‘”–‡••‘ˆ„”‡ƒ–ŠǤ

ͻǤ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒ‹…Ž—†‹‰‘Ǧ’Šƒ”ƒ…‘Ž‘‰‹…ƒŽƒ†

’Šƒ”ƒ…‘Ž‘‰‹…ƒŽƒƒ‰‡‡–ˆ‘”•–ƒ„Ž‡’ƒ–‹‡–•ƒ†’ƒ–‹‡–•™‹–Šƒ…—–‡

‡šƒ…‡”„ƒ–‹‘Ǥ

ͳͲǤ ••‡••”‡•’‘•‡–‘–”‡ƒ–‡–Ǥ

ͳͳǤ ‡…‘‰‹œ‡–Š‡‹†‹…ƒ–‹‘•‘ˆŽ‘‰Ǧ–‡”‘š›‰‡–Š‡”ƒ’›Ǥ

ͳʹǤ †‡–‹ˆ›’ƒ–‹‡–•–Šƒ–ƒ”‡•—‹–ƒ„Ž‡ˆ‘”‘Ǧ˜ƒ•‹˜‡‡–‹Žƒ–‹‘ȋȌǤ ͳ͵Ǥ †‡–‹ˆ›‹–‡”˜‡–‹‘•–Šƒ–”‡†—…‡‘”–ƒŽ‹–›‹Ǥ

ͳͶǤ ‡•…”‹„‡–Š‡‹’ƒ…–‘ˆ…‹‰ƒ”‡––‡•‘‹‰‘–Š‡”‡•’‹”ƒ–‘”›•›•–‡Ǥ ͳͷǤ ’’”‘’”‹ƒ–‡Ž›’”‹‘”‹–‹œ‡–Š‡”‡ˆ‡””ƒŽ–‘‡•’‹”ƒ–‘”›Ž‹‹…Ǥ

ͳ͸Ǥ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Pneumonia {‘—‹–›ƒ…“—‹”‡† (CAP), ‘•’‹–ƒŽƒ…“—‹”‡† (HAP) ‡–‹Žƒ–‘”ƒ••‘…‹ƒ–‡†

(VAP)}

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›‘ˆ’ƒ–‹‡–•™‹–Š…‘—‰Šƒ†ˆ‡˜‡”Ǥ ʹǤ ‡”ˆ‘”ƒ…‘’Ž‡–‡•›•–‡ƒ–‹…’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘ˆ‘”ƒ’ƒ–‹‡–™‹–Š…‘—‰Šƒ†

ˆ‡˜‡”Ǥ

͵Ǥ ‡ˆ‹‡ǡǡƒ†Ǥ

ͶǤ †‡–‹ˆ›–Š‡…‘‘‹…”‘„‹‘Ž‘‰‹…ƒŽ‘”‰ƒ‹••‘ˆǡǡƒ†Ǥ

ͷǤ Š‘‘•‡–Š‡ƒ’’”‘’”‹ƒ–‡Žƒ„‘”ƒ–‘”›Ȁ‹ƒ‰‹‰–‡•–•–‘‡˜ƒŽ—ƒ–‡’ƒ–‹‡–•™‹–Š’‘••‹„Ž‡

’‡—‘‹ƒǤ

͸Ǥ –‡”’”‡––Š‡ˆ‹†‹‰••—‰‰‡•–‹˜‡‘ˆ’‡—‘‹ƒƒ††‹•–‹‰—‹•Š†‹ˆˆ‡”‡–…ƒ—•‡•

‘ˆƒŽ˜‡‘Žƒ”’ƒ––‡”Ǥ

͹Ǥ ‘”—Žƒ–‡ƒ†’”‹‘”‹–‹œ‡ƒ†‹ˆˆ‡”‡–‹ƒŽ†‹ƒ‰‘•‹•ˆ‘”’ƒ–‹‡–•™‹–Š…‘—‰Šƒ†ˆ‡˜‡”Ǥ ͺǤ ‡…‘‰‹œ‡ƒ†’”‹‘”‹–‹œ‡’ƒ–‹‡–•™‹–Š™Š‘‡‡†Š‘•’‹–ƒŽƒ†‹••‹‘•Ǥ ͻǤ –‹Ž‹œ‡–Š‡Ǧ͸ͷ’‡—‘‹ƒ•‡˜‡”‹–›•…‘”‹‰•›•–‡Ǥ

ͳͲǤ ‹•––Š‡…ƒ—•‡•‘ˆ‘Ǧ”‡•‘Ž˜‹‰’‡—‘‹ƒǤ

ͳͳǤ ‡•…”‹„‡’‡—‘‹ƒ…‘’Ž‹…ƒ–‹‘•ƒ†–Š‡‹”ƒ’’”‘’”‹ƒ–‡ƒƒ‰‡‡–Ǥ ͳʹǤ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”’‡—‘‹ƒƒƒ‰‡‡–ȋǡ

ǡƒ†ȌǤ

ͳ͵Ǥ ‘”—Žƒ–‡ƒˆ‘ŽŽ‘™—’’Žƒˆ‘”’ƒ–‹‡–™‹–Šǡǡƒ†Ǥ ͳͶǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Pleural Effusion

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡Š‹•–‘”›‘ˆ’ƒ–‹‡–™‹–Š•Š‘”–‡••‘ˆ„”‡ƒ–Šƒ†Ȁ‘”’Ž—”‹–‹…

…Š‡•–’ƒ‹Ǥ

ʹǤ ‡”ˆ‘”…Š‡•–’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘–‘‡•–ƒ„Ž‹•Š–Š‡’”‡•‡…‡‘ˆ’Ž‡—”ƒŽ‡ˆˆ—•‹‘Ǥ

͵Ǥ ‹ˆˆ‡”‡–‹ƒ–‡„‡–™‡‡‡š—†ƒ–‹˜‡ǡ–”ƒ•—†ƒ–‹˜‡’Ž‡—”ƒŽ‡ˆˆ—•‹‘ǡƒ†‡’›‡ƒǤ ͶǤ ‹•–…ƒ—•‡•‘ˆ‡š—†ƒ–‹˜‡ǡ–”ƒ•—†ƒ–‹˜‡’Ž‡—”ƒŽ‡ˆˆ—•‹‘ǡƒ†‡’›‡ƒǤ

ͷǤ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡‹ƒ‰‹‰Ȁ’Ž‡—”ƒŽˆŽ—‹†‹˜‡•–‹‰ƒ–‹‘•–‘†‹ƒ‰‘•‡

†‹ˆˆ‡”‡––›’‡•‘ˆ’Ž‡—”ƒŽ‡ˆˆ—•‹‘Ǥ

͸Ǥ †‡–‹ˆ›ˆ‹†‹‰•…‘’ƒ–‹„Ž‡™‹–Š’Ž‡—”ƒŽ‡ˆˆ—•‹‘Ǥ

͹Ǥ –‡”’”‡––Š‡”‡•—Ž–•‘ˆ’Ž‡—”ƒŽˆŽ—‹†–‡•–•Ǥ

ͺǤ —†‰‡™Š‡’Ž‡—”ƒŽ†”ƒ‹ƒ‰‡‹•ƒ’’”‘’”‹ƒ–‡ƒ†•ƒˆ‡Ǥ ͻǤ ••‡••–Š‡’”‡Ǧ”‡“—‹•‹–‡‡ƒ•—”‡•‘ˆ•ƒˆ‡’Ž‡—”ƒŽ–ƒ’’‹‰Ǥ ͳͲǤ ’Ž‘›–Š‡†‹ƒ‰‘•–‹…—–‹Ž‹–‹‡•‘ˆ†‹ˆˆ‡”‡–’Ž‡—”ƒŽˆŽ—‹†–‡•–•Ǥ

ͳͳǤ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”†‹ˆˆ‡”‡––›’‡•‘ˆ’Ž‡—”ƒŽ‡ˆˆ—•‹‘Ǥ ͳʹǤ ’’”‘’”‹ƒ–‡Ž›’”‹‘”‹–‹œ‡”‡ˆ‡””ƒŽ–‘‡•’‹”ƒ–‘”›ȀŠ‘”ƒ…‹…•—”‰‡”›Ž‹‹…Ǥ

Venous Thromboembolism (VTE): Pulmonary Embolism (PE) ans Deep Vein Thrombosis (DVT)

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›‘ˆ’ƒ–‹‡–•™‹–ŠȀǤ

ʹǤ ‡”ˆ‘”ƒ…‘’Ž‡–‡•›•–‡ƒ–‹…’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘ˆ‘”’ƒ–‹‡–™‹–ŠȀǤ

͵Ǥ ‡…‘‰‹œ‡”‹•ˆƒ…–‘”•ˆ‘”ȀǤ

ͶǤ ‹•–‹‰—‹•Š„‡–™‡‡’”‘˜‘‡†ƒ†—’”‘˜‘‡†ȀǤ ͷǤ ‹•––Š‡‹Š‡”‹–‡†–Š”‘„‘’Š‹Ž‹ƒ†‹•‡ƒ•‡•Ǥ

͸Ǥ –‹Ž‹œ‡–Š‡’”‡Ǧtest probability scoring tool for PE/DVT (Well’s score).

ͻǤ ‡Žƒ–‡–Š‡”‘Ž‡‘ˆǦ‹‡”ƒ†‹–•‹–‡”’”‡–ƒ–‹‘„ƒ•‡†‘–Š‡…Ž‹‹…ƒŽ’”‘„ƒ„‹Ž‹–›Ǥ ͳͲǤ–‡”’”‡–ƒ”–‡”‹ƒŽ„Ž‘‘†‰ƒ•‡•‹–Š‡•‡––‹‰‘ˆ•—•’‡…–‡†Ǥ

ͳͳǤ †‡–‹ˆ›‡›ƒ„‘”ƒŽ‹–‹‡•‘ƒ†‹•—•’‡…–‡†Ǥ ͳʹǤ ‡…‘‰‹œ‡Ž‹‹–ƒ–‹‘•‘ˆ†‹ˆˆ‡”‡–†‹ƒ‰‘•–‹…–‡•–•‹Ǥ ͳ͵Ǥ ‡…‘‰‹œ‡–Š‡‹†‹…ƒ–‹‘•‘ˆŠ”‘„‘Ž›–‹…–Š‡”ƒ’›Ǥ ͳͶǤ‡…‘‰‹œ‡ƒ…—–‡ƒ†…Š”‘‹……‘’Ž‹…ƒ–‹‘•‘ˆǤ

ͳͷǤ ‘”—Žƒ–‡ƒ†’”‹‘”‹–‹œ‡ƒ†‹ˆˆ‡”‡–‹ƒŽ†‹ƒ‰‘•‹•ˆ‘”˜‡‘—•–Š”‘„‘‡„‘Ž‹•

ȋǡȌǤ

ͳ͸Ǥ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”ȀǤ

ͳ͹Ǥ ’’”‘’”‹ƒ–‡Ž›’”‹‘”‹–‹œ‡–Š‡”‡ˆ‡””ƒŽ–‘Š‡ƒ–‘Ž‘‰›Ȁƒ–‹…‘ƒ‰—Žƒ–‹‘…Ž‹‹…Ǥ ͳͺǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Tuberculosis (TB)

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡Š‹•–‘”›–‘’ƒ–‹‡–•™‹–Š—Ž‘ƒ”›‘”‡š–”ƒǦ’—Ž‘ƒ”›Ǥ

ʹǤ ‡”ˆ‘”ƒˆ‘…—•‡†…Š‡•–’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘–‘ƒ••‡••’‘–‡–‹ƒŽ…‘’Ž‹…ƒ–‹‘•‘ˆ

’—Ž‘ƒ”›ȋ‡ˆˆ—•‹‘ǡ…‘ŽŽƒ’•‡ǡ”‘…Š‡ƒ…–‹ƒ‹•‹•Ȍ

͵Ǥ ‡”ˆ‘”ƒ•›•–‡‹…’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘–‘ƒ••‡••ˆ‘”‡š–”ƒǦ’—Ž‘ƒ”›•‹‰•Ǥ ͶǤ ‡…‘‰‹œ‡–Š‡†‹ˆˆ‡”‡…‡„‡–™‡‡ƒ…–‹˜‡—Ž‘ƒ”›ƒ†Žƒ–‡–Ǥ

ͷǤ †‡”•–ƒ†–Š‡†‹ƒ‰‘•–‹…›‹‡Ž†•‘ˆ†‹ˆˆ‡”‡––‡•–•ˆ‘”…–‹˜‡—Ž‘ƒ”›ȋ

•–ƒ‹ǡ•’—–—…—Ž–—”‡ǡƒ†ȌǤ

͸Ǥ ‡•…”‹„‡›‹‡Ž†‘ˆ•‹–‡•–ƒ†—ƒ–‹ˆ‡”‘–‡•–•‹Žƒ–‡–†‹ƒ‰‘•‹•Ǥ

͹Ǥ †‡–‹ˆ›”‡†ˆŽƒ‰•›’–‘•ƒ†”‹•ˆƒ…–‘”•‘ˆˆ”‘Š‹•–‘”›ƒ†ƒ’’Ž›–Š‡

ƒ’’”‘’”‹ƒ–‡‹ˆ‡…–‹‘…‘–”‘Ž’”‡…ƒ—–‹‘Ǥ

ͺǤ Š‘‘•‡–Š‡ƒ’’”‘’”‹ƒ–‡–‡•–•Ȁ‹ƒ‰‹‰–‘†‹ƒ‰‘•‡ƒ…–‹˜‡Ǥ ͻǤ Š‘‘•‡–Š‡ƒ’’”‘’”‹ƒ–‡–‡•–•Ȁ‹ƒ‰‹‰–‘†‹ƒ‰‘•‡Žƒ–‡–Ǥ

ͳͲǤŠ‘‘•‡–Š‡ƒ’’”‘’”‹ƒ–‡‹˜‡•–‹‰ƒ–‹‘•–‘•…”‡‡…Ž‘•‡…‘–ƒ…–•‘ˆƒ…–‹˜‡’ƒ–‹‡–•Ǥ ͳͳǤ ‡•…”‹„‡…‘’Ž‹…ƒ–‹‘•‘ˆ—Ž‘ƒ”›ƒ†‡š–”ƒǦ’—Ž‘ƒ”›Ǥ

ͳʹǤ ‡…‘‰‹œ‡”‹•ˆƒ…–‘”•‘ˆƒ…–‹˜ƒ–‹‘‘ˆŽƒ–‡–Ǥ ͳ͵Ǥ‹ˆˆ‡”‡–‹ƒ–‡„‡–™‡‡ƒ…–‹˜‡ƒ†Žƒ–‡––”‡ƒ–‡–Ǥ ͳͶǤ ‡•…”‹„‡–Š‡„ƒ•‹…’Šƒ”ƒ…‘Ž‘‰›‘ˆƒ–‹Ǧ‡†‹…ƒ–‹‘•Ǥ

ͳͷǤ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”ƒ…–‹˜‡ƒ†Žƒ–‡–Ǥ ͳ͸Ǥ ’’”‘’”‹ƒ–‡Ž›’”‹‘”‹–‹œ‡–Š‡”‡ˆ‡””ƒŽ–‘Ȁ‡•’‹”ƒ–‘”›…Ž‹‹…Ǥ

ͳ͹Ǥ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Obstructive Sleep Apnea (OSA)

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ ͳǤ ‡…‘‰‹•‡•›’–‘••—‰‰‡•–‹˜‡‘ˆǤ

ʹǤ „–ƒ‹ƒˆ‘…—•‡†Š‹•–‘”›–‘•…”‡‡ˆ‘”Ǥ

͵Ǥ ‡•…”‹„‡‡ˆˆ‡…–‘ˆ‘‡–ƒ„‘Ž‹…•›†”‘‡Ǥ

ͶǤ ”ƒ…–‹…‡…ƒŽ…—Žƒ–‹‰ƒ†…Žƒ••‹ˆ›–Š‡patient’s obesity.

ͷǤ —–Ž‹‡–Š‡…‘’Ž‹…ƒ–‹‘•‘ˆǤ

͸Ǥ —–Ž‹‡–Š‡–”‡ƒ–‡–‘’–‹‘•ˆ‘”Ǥ

͹Ǥ ”‹‘”‹–‹œ‡–Š‡”‡ˆ‡””ƒŽ–‘‡•’‹”ƒ–‘”›Ȁ•Ž‡‡’‡†‹…‹‡…Ž‹‹…Ǥ

Module B Core Endocrinology Diseases

Obesity

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒƒ……—”ƒ–‡ƒ†…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›‘ˆƒ‘„‡•‡’ƒ–‹‡–ǡˆ‘…—•‹‰

‘Ž‹ˆ‡•–›Ž‡ǡ—†‡”Ž›‹‰…ƒ—•‡ƒ†…‘’Ž‹…ƒ–‹‘•Ǥ

ʹǤ ‡”ˆ‘”ƒ’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘ˆ‘…—•‹‰‘‘„‡•‹–›”‡Žƒ–‡†…‘’Ž‹…ƒ–‹‘•Ǥ

͵Ǥ ‡ˆ‹‡‘„‡•‹–›ƒ†“—ƒ–‹ˆ›‹–Ǥ

ͶǤ †‡–‹ˆ›–Š‡‡–‹‘Ž‘‰›‘ˆ‘„‡•‹–›ƒ†‹–•”‡˜‡”•‹„Ž‡…ƒ—•‡•Ǥ ͷǤ ‡˜‡Ž‘’ƒ…Ž‹‹…ƒŽƒ••‡••‡–ƒ’’”‘ƒ…Š–‘‘„‡•‹–›Ǥ

͸Ǥ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡‹˜‡•–‹‰ƒ–‹‘•–‘‡š…Ž—†‡”‡˜‡”•‹„Ž‡…ƒ—•‡•‘ˆ‘„‡•‹–›Ǥ

͹Ǥ ‹•–‘„‡•‹–›”‡Žƒ–‡†…‘’Ž‹…ƒ–‹‘•Ǥ

ͺǤ †‡–‹ˆ›–Š‡‹†‹…ƒ–‹‘•ˆ‘”‡†‹…ƒŽƒ†•—”‰‹…ƒŽ–”‡ƒ–‡–‘ˆ‘„‡•‹–›Ǥ ͻǤ †‡–‹ˆ›–Š‡–›’‡•‘ˆƒ”‹ƒ–”‹…•—”‰‡”‹‡•ƒ†–Š‡‹”ƒ†˜‡”•‡‡ˆˆ‡…–•Ǥ ͳͲǤ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”‘„‡•‹–›Ǥ ͳͳǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Diabetes Mellitus (DM)

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›‘ˆƒ†‹–•…‘’Ž‹…ƒ–‹‘•Ǥ

ʹǤ ‡”ˆ‘”ƒ…‘’Ž‡–‡’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘ˆ‘”•…”‡‡‹‰‘ˆ…‘’Ž‹…ƒ–‹‘•

ȋ‹…Ž—†‹‰”‡–‹‘’ƒ–Š›ƒ††‹ƒ„‡–‹…ˆ‡‡–Ȍƒ†‹Œ‡…–‹‘•‹–‡•Ǥ

͵Ǥ ‡…‘‰‹œ‡–Š‡†‹ˆˆ‡”‡––›’‡•‘ˆȋ–›’‡ͳǡ–›’‡ʹǡ‰‡•–ƒ–‹‘ƒŽǡ

ƒ–—”‡‘•‡–†‹ƒ„‡–‡•‘ˆ›‘—‰ǡƒ†Žƒ–‡ƒ—–‘‹—‡†‹ƒ„‡–‡•‘ˆƒ†—Ž–•

Ȍƒ†Š‘™–‘†‹ˆˆ‡”‡–‹ƒ–‡„‡–™‡‡–Š‡…Ž‹‹…ƒŽŽ›ƒ†„‹‘…Š‡‹…ƒŽŽ›Ǥ ͶǤ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡Žƒ„‘”ƒ–‘”›–‡•–•–‘•…”‡‡Ȁ†‹ƒ‰‘•‡„ƒ•‡†‘–Š‡

ƒ˜ƒ‹Žƒ„Ž‡…Ž‹‹…ƒŽ†ƒ–ƒǤ

ͷǤ —–Ž‹‡–Š‡ƒ†˜ƒ–ƒ‰‡•ƒ†’‹–ˆƒŽŽ•‘ˆ–Š‡•…”‡‡‹‰Ȁ†‹ƒ‰‘•–‹…–‡•–•Ǥ

͸Ǥ ‡…‘‰‹œ‡–Š‡–ƒ”‰‡–•ˆ‘”ƒ…‘–”‘ŽŽ‡†Ǥ

͹Ǥ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒ†…‘•–Ǧ‡ˆˆ‡…–‹˜‡ƒƒ‰‡‡–’Žƒˆ‘”ͳƒ†

ʹ–ƒ‹‰‹–‘…‘•‹†‡”ƒ–‹‘–Š‡ƒ†˜ƒ–ƒ‰‡•Ȁ†‹•ƒ†˜ƒ–ƒ‰‡•‘ˆ‡ƒ…Š–”‡ƒ–‡–

modality and patient’s characteristics and preferences.

ͺǤ ‡•…”‹„‡–Š‡„ƒ•‹…’Šƒ”ƒ…‘Ž‘‰›‘ˆ‘”ƒŽƒ†‹Œ‡…–ƒ„Ž‡ƒ–‹Ǧ†‹ƒ„‡–‹…‡†‹…ƒ–‹‘•ǡ

–Š‡‹”‹†‹…ƒ–‹‘•ǡ…‘–”ƒ‹†‹…ƒ–‹‘•ǡƒ†•‹†‡‡ˆˆ‡…–•Ǥ ͻǤ †‡–‹ˆ›–Š‡•—”‰‹…ƒŽ”‘Ž‡‹ƒƒ‰‡‡–Ǥ

ͳͲǤ ‡…‘‰‹œ‡–Š‡…Ž‹‹…ƒŽˆ‡ƒ–—”‡•Ȁ”‡†ˆŽƒ‰•‘ˆƒ…—–‡…‘’Ž‹…ƒ–‹‘•ȋǡǡ

›’‘‰Ž›…‡‹ƒȌǤ

ͳͳǤ ŽŽ—•–”ƒ–‡ƒ•…Š‡ƒ–‹…ƒ’’”‘ƒ…Šˆ‘”•…”‡‡‹‰ƒ†ƒƒ‰‡‡–‘ˆ˜ƒ•…—Žƒ”

…‘’Ž‹…ƒ–‹‘•

ͳʹǤ’’”‘’”‹ƒ–‡Ž›’”‹‘”‹–‹œ‡”‡ˆ‡””ƒŽ–‘†‘…”‹‡Ž‹‹…Ǥ ͳ͵Ǥ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Thyroid disorders

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›‘ˆŠ›’‡”–Š›”‘‹†‹•ǡŠ›’‘–Š›”‘‹†‹•ǡƒ†

–Š›”‘‹†‘†—Ž‡Ȁ‰‘‹–‡”Ǥ

ʹǤ ‡”ˆ‘”ƒ…‘’Ž‡–‡•›•–‡ƒ–‹…’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘ˆ‘”Š›’‡”–Š›”‘‹†‹•ǡ

Š›’‘–Š›”‘‹†‹•ǡƒ†‘†—Ž‡Ȁ‰‘‹–‡”Ǥ

͵Ǥ ‡‘•–”ƒ–‡–Š‡…‘””‡…––‡…Š‹“—‡‘ˆ–Š›”‘‹†‡šƒ‹ƒ–‹‘Ǥ ͶǤ Žƒ••‹ˆ›–Š‡…ƒ—•‡•‘ˆŠ›’‡”–Š›”‘‹†‹•ƒ†Š›’‘–Š›”‘‹†‹•Ǥ

ͷǤ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡Žƒ„‘”ƒ–‘”›Ȁ‹ƒ‰‹‰‹˜‡•–‹‰ƒ–‹‘•–‘†‹ƒ‰‘•‡–Š›”‘‹†

†‹•‘”†‡”•„ƒ•‡†‘–Š‡ƒ˜ƒ‹Žƒ„Ž‡…Ž‹‹…ƒŽ†ƒ–ƒǤ

‘†—Ž‡Ȁ‰‘‹–‡”Ǥ

ͺǤ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”Š›’‘–Š›”‘‹†‹•ǡŠ›’‡”–Š›”‘‹†‹•ǡ

ƒ†–Š›”‘‹†‘†—Ž‡•Ȁ‰‘‹–‡”–ƒ‹‰‹–‘…‘•‹†‡”ƒ–‹‘–Š‡

advantages/disadvantages of each treatment modality and patient’s preferences.

ͻǤ ‡ˆ‹‡–Š‡‹†‹…ƒ–‹‘•ƒ†…‘–”ƒ‹†‹…ƒ–‹‘•‘ˆ”ƒ†‹‘ƒ…–‹˜‡‹‘†‹‡ƒ„Žƒ–‹‘ƒ†

–Š›”‘‹†•—”‰‡”›‹–”‡ƒ–‡–‘ˆŠ›’‡”–Š›”‘‹†‹•Ǥ

ͳͲǤ ‡•…”‹„‡–Š‡’‘•–‘’‡”ƒ–‹˜‡…‘’Ž‹…ƒ–‹‘•‘ˆ–Š›”‘‹†•—”‰‡”‹‡•Ǥ

ͳͳǤ †‡–‹ˆ›–Š‡”‡†ˆŽƒ‰…Ž‹‹…ƒŽˆ‡ƒ–—”‡•‘ˆ–Š›”‘‹†•–‘”ƒ†›š‡†‡ƒ…‘ƒǤ ͳʹǤ ’’”‘’”‹ƒ–‡Ž›’”‹‘”‹–‹œ‡–Š‡”‡ˆ‡””ƒŽ–‘†‘…”‹‡Ž‹‹…Ǥ

ͳ͵Ǥ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Parathyroid and calcium disorders

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›‘ˆŠ›’‘Ǧƒ†Š›’‡”…ƒŽ…‡‹ƒǡƒ†˜‹–ƒ‹

†‡ˆ‹…‹‡…›Ǥ

ʹǤ ‡”ˆ‘”ƒ…‘’Ž‡–‡•›•–‡ƒ–‹…’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘ˆ‘”Š›’‘Ǧƒ†Š›’‡”…ƒŽ…‡‹ƒǤ

͵Ǥ ‡ˆ‹‡–Š‡‡–‹‘Ž‘‰›‘ˆŠ›’‘Ǧƒ†Š›’‡”…ƒŽ…‡‹ƒǡ˜‹–ƒ‹†‡ˆ‹…‹‡…›ƒ†‡š…‡••Ǥ ͶǤ †‡–‹ˆ›–Š‡…‘•‡“—‡…‡•Ȁ…‘’Ž‹…ƒ–‹‘•‘ˆŠ›’‘Ǧƒ†Š›’‡”…ƒŽ…‡‹ƒǡ˜‹–ƒ‹

†‡ˆ‹…‹‡…›ƒ†‡š…‡••ȋ‘•–‡‘ƒŽƒ…‹ƒƒ†‘•–‡‘’‘”‘•‹•ȌǤ

ͷǤ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡Žƒ„‘”ƒ–‘”›Ȁ‹ƒ‰‹‰–‡•–•–‘‹˜‡•–‹‰ƒ–‡…ƒ—•‡•‘ˆ

Š›’‘Ǧƒ†Š›’‡”…ƒŽ…‡‹ƒǡƒ†‹–‡”’”‡––Š‡‹””‡•—Ž–•Ǥ

͸Ǥ ‘”—Žƒ–‡ƒ†’”‹‘”‹–‹œ‡ƒ†‹ˆˆ‡”‡–‹ƒŽ†‹ƒ‰‘•‹•ˆ‘”…ƒŽ…‹—‹„ƒŽƒ…‡Ǥ

͹Ǥ ‡•…”‹„‡–Š‡„ƒ•‹…•’Šƒ”ƒ…‘Ž‘‰›‘ˆ‡†‹…ƒ–‹‘•—•‡†‹–”‡ƒ–‡–‘ˆ…ƒŽ…‹—ƒ†

˜‹–ƒ‹‹„ƒŽƒ…‡Ǥ

ͺǤ —–Ž‹‡–Š‡”‘Ž‡‘ˆ•—”‰‡”›”‡Žƒ–‡†–‘–”‡ƒ–‡–‘ˆŠ›’‡”’ƒ”ƒ–Š›”‘‹†‹•Ǥ

ͻǤ ‡˜‡Ž‘’ƒ‡˜‹†‡…‡Ǧ„ƒ•‡†ƒƒ‰‡‡–’Žƒˆ‘”…ƒŽ…‹—ƒ†˜‹–ƒ‹‹„ƒŽƒ…‡Ǥ ͳͲǤ’’”‘’”‹ƒ–‡Ž›’”‹‘”‹–‹œ‡–Š‡”‡ˆ‡””ƒŽ–‘†‘…”‹‡Ž‹‹…Ǥ

ͳͳǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Pituitary Disorders

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›ˆ”‘’ƒ–‹‡–•™‹–Š’‹–—‹–ƒ”›†‹•‘”†‡”•Ǥ

ʹǤ ‡”ˆ‘”ƒ…‘’Ž‡–‡•›•–‡ƒ–‹…’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘ˆ‘”’ƒ–‹‡–•™‹–Š’‹–—‹–ƒ”›

†‹•‘”†‡”•Ǥ

͵Ǥ ‘•–”—…–ƒ†‹ƒ‰‘•–‹…ƒ’’”‘ƒ…Š–‘Š›’‘’‹–—‹–ƒ”‹•ǡŠ›’‡”’”‘Žƒ…–‹‡‹ƒǡƒ†

ƒ…”‘‡‰ƒŽ›Ǥ

ͶǤ —–Ž‹‡–Š‡‡†‹…ƒŽƒƒ‰‡‡–‘ˆŠ›’‘’‹–—‹–ƒ”‹•Ǥ ͷǤ —–Ž‹‡–Š‡‡†‹…ƒŽƒƒ‰‡‡–‘’–‹‘•ˆ‘”’”‘Žƒ…–‹‘ƒǤ

͸Ǥ †‡–‹ˆ›–Š‡…‘’Ž‹…ƒ–‹‘•‘ˆ—–”‡ƒ–‡†ƒ…”‘‡‰ƒŽ›Ǥ

͹Ǥ —–Ž‹‡–Š‡‡†‹…ƒŽƒ†•—”‰‹…ƒŽƒƒ‰‡‡–‘’–‹‘•ˆ‘”ƒ…”‘‡‰ƒŽ›Ǥ ͺǤ ’’”‘’”‹ƒ–‡Ž›’”‹‘”‹–‹œ‡–Š‡”‡ˆ‡””ƒŽ–‘†‘…”‹‡Ž‹‹…Ǥ

ͻǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Adrenal disorders

›–Š‡‡†‘ˆ‘†—Ž‡ǡ•–—†‡–••Š‘—Ž†„‡ƒ„Ž‡–‘ǣ

ͳǤ „–ƒ‹ƒ…‘’”‡Š‡•‹˜‡‡†‹…ƒŽŠ‹•–‘”›ˆ”‘’ƒ–‹‡–•™‹–Šƒ†”‡ƒŽ†‹•‘”†‡”•Ǥ ʹǤ ‡”ˆ‘”ƒ…‘’Ž‡–‡•›•–‡ƒ–‹…’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘ˆ‘”’ƒ–‹‡–•™‹–Šƒ†”‡ƒŽ

†‹•‘”†‡”•Ǥ

͵Ǥ ‹ˆˆ‡”‡–‹ƒ–‡„‡–™‡‡’”‹ƒ”›ƒ†•‡…‘†ƒ”›ƒ†”‡ƒŽ‹•—ˆˆ‹…‹‡…›…Ž‹‹…ƒŽŽ›ƒ†

„‹‘…Š‡‹…ƒŽŽ›Ǥ

ͶǤ †‡–‹ˆ›–Š‡…Ž‹‹…ƒŽˆ‡ƒ–—”‡•‘ˆ††‹•‘‹ƒ…”‹•‹•Ǥ

ͷǤ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡Žƒ„‘”ƒ–‘”›Ȁ‹ƒ‰‹‰–‡•–•–‘‹˜‡•–‹‰ƒ–‡…ƒ—•‡•‘ˆ

ƒ†”‡ƒŽ‹•—ˆˆ‹…‹‡…›Ǥ

ͺǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘‘ˆƒ†”‡ƒŽ‹•—ˆˆ‹…‹‡…›

ƒ†•–‡”‘‹†•–”‡••†‘•‹‰Ǥ

ͻǤ Identify the red flag symptoms and signs to suspect Cushing’s.

ͳͲǤ Classify the causes of Cushing’s as ACTHǦ†‡’‡†‡–ƒ†‹†‡’‡†‡–…ƒ—•‡•Ǥ ͳͳǤ Outline the complications of Cushing’s and the consequences if untreated.

ͳʹǤŠ‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡•…”‡‡‹‰ƒ†…‘ˆ‹”ƒ–‘”›Žƒ„‘”ƒ–‘”›Ȁ‹ƒ‰‹‰–‡•–•

for Cushing’s.

ͳ͵Ǥ Describe the role of medical and surgical management of Cushing’s.

ͳͶǤ Outline the follow up plan for Cushing’s patient postǦ–”‡ƒ–‡–Ǥ

ͳͷǤ †‡–‹ˆ›–Š‡”‡†ˆŽƒ‰•›’–‘•ƒ†•‹‰•–‘•—•’‡…–Š›’‡”ƒŽ†‘•–‡”‘‹•Ǥ

ͳ͸Ǥ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡•…”‡‡‹‰ƒ†…‘ˆ‹”ƒ–‘”›Žƒ„‘”ƒ–‘”›Ȁ‹ƒ‰‹‰–‡•–•

ˆ‘”Š›’‡”ƒŽ†‘•–‡”‘‹•Ǥ

ͳ͹Ǥ –‡”’”‡––Š‡”‡•—Ž–•‘ˆŽƒ„‘”ƒ–‘”›–‡•–•—•‡†‹•…”‡‡‹‰ƒ†…‘ˆ‹”‹‰–Š‡

†‹ƒ‰‘•‹•‘ˆŠ›’‡”ƒŽ†‘•–‡”‘‹•Ǥ

ͳͺǤ †‡–‹ˆ›–Š‡…‘’Ž‹…ƒ–‹‘•‘ˆ—–”‡ƒ–‡†Š›’‡”ƒŽ†‘•–‡”‘‹•Ǥ

ͳͻǤ —–Ž‹‡–Š‡‡†‹…ƒŽƒ†•—”‰‹…ƒŽƒƒ‰‡‡–‘’–‹‘•ˆ‘”Š›’‡”ƒŽ†‘•–‡”‘‹•Ǥ ʹͲǤ†‡–‹ˆ›–Š‡”‡†ˆŽƒ‰•›’–‘•ƒ†•‹‰•–‘•—•’‡…–’Š‡‘…Š”‘‘…›–‘ƒǤ

ʹͳǤ Š‘‘•‡–Š‡‘•–ƒ’’”‘’”‹ƒ–‡•…”‡‡‹‰ƒ†…‘ˆ‹”ƒ–‘”›Žƒ„‘”ƒ–‘”›Ȁ‹ƒ‰‹‰–‡•–•

ˆ‘”’Š‡‘…Š”‘‘…›–‘ƒǤ

ʹʹǤ ‡˜‡Ž‘’ƒƒƒ‰‡‡–’Žƒˆ‘”Š›’‡”–‡•‹‘…ƒ—•‡†„›’Š‡‘…Š”‘‘…›–‘ƒǤ ʹ͵Ǥ †‡–‹ˆ›–Š‡…‘’Ž‹…ƒ–‹‘•‘ˆ—–”‡ƒ–‡†’Š‡‘…Š”‘‘…›–‘ƒǤ

ʹͶǤ —–Ž‹‡–Š‡”‘Ž‡‘ˆ‡†‹…ƒŽƒ†•—”‰‹…ƒŽƒƒ‰‡‡–‘ˆ’Š‡‘…Š”‘‘…›–‘ƒǤ ʹͷǤ †‡–‹ˆ›–Š‡…linical features of a functional adrenal ‘incidentaloma’.

ʹ͸Ǥ List the investigations used to assess the function of adrenal ‘incidentaloma’.

ʹ͹ǤIdentify the imaging features suggestive of a malignant adrenal ‘incidentaloma’Ǥ ʹͺǤ ’’”‘’”‹ƒ–‡Ž›’”‹‘”‹–‹œ‡–Š‡”‡ˆ‡””ƒŽ–‘†‘…”‹‡Ž‹‹…Ǥ

ʹͻǤ ‡‘•–”ƒ–‡–Š‡ƒ’’”‘’”‹ƒ–‡•‹ŽŽ•ˆ‘”’ƒ–‹‡–‡†—…ƒ–‹‘Ǥ

Year 4

^Portfolio

Items for Module B:

Task ^Required

numbers Evaluation Evaluator

Mini-CEX ʹ ‘’Ž‡–‹‘ȗ ‡‹‘””‡•‹†‡–Ȁ‘•—Ž–ƒ–

CBD ͳ ‘’‡–‡…‡ȗȗ ƒ…—Ž–›•–ƒˆˆ

Clerking

(Documentation) ͵ ‘’‡–‡…‡Ȁ…‘’Ž‡–‹‘ ‡‹‘””‡•‹†‡–Ȁ’‡…‹ƒŽ‹•–Ȁ

‘•—Ž–ƒ–

EBP (evidence based

prescription) ͳ ‘’Ž‡–‹‘ ‡‹‘””‡•‹†‡–Ȁ‘•—Ž–ƒ–Ȁ

ƒ…—Ž–›•–ƒˆˆ

Procedure card ͳ ‡”ˆ‘”ƒ…‡Ȁ…‘’Ž‡–‹‘ ‡‹‘””‡•‹†‡–Ȁ‘•—Ž–ƒ–Ȁ—”•‡

†‡’‡†‹‰‘’”‘…‡†—”‡

ECG reports ͵ ‘’‡–‡…‡ ‡‹‘””‡•‹†‡–Ȁ’‡…‹ƒŽ‹•–Ȁ

‘•—Ž–ƒ–Ȁ ƒ…—Ž–›•–ƒˆˆ

ABG interpretation ʹ ‘’‡–‡…‡ ‡‹‘””‡•‹†‡–Ȁ’‡…‹ƒŽ‹•–Ȁ

‘•—Ž–ƒ–Ȁ ƒ…—Ž–›•–ƒˆˆ

PFT report ͳ ‘’Ž‡–‹‘ ‡‹‘””‡•‹†‡–Ȁ’‡…‹ƒŽ‹•–Ȁ

‘•—Ž–ƒ–Ȁ ƒ…—Ž–›•–ƒˆˆ

Pleural fluid analysis ͳ ‘’Ž‡–‹‘ ‡‹‘””‡•‹†‡–Ȁ’‡…‹ƒŽ‹•–Ȁ

‘•—Ž–ƒ–Ȁ ƒ…—Ž–›•–ƒˆˆ

CXR reports Ͷ ‘’‡–‡…‡ ‡‹‘””‡•‹†‡–Ȁ’‡…‹ƒŽ‹•–Ȁ

‘•—Ž–ƒ–Ȁ ƒ…—Ž–›•–ƒˆˆ

VTE project ͳ ‘’‡–‡…‡ ‡‹‘””‡•‹†‡–Ȁ’‡…‹ƒŽ‹•–Ȁ

‘•—Ž–ƒ–Ȁ ƒ…—Ž–›•–ƒˆˆ

Radiology department

visit (2-3 hr) ͳ ‡”ˆ‘”ƒ…‡Ȁ…‘’Ž‡–‹‘ ƒ†‹‘Ž‘‰›‡‹‘””‡•‹†‡–Ȁ

’‡…‹ƒŽ‹•–Ȁ‘•—Ž–ƒ–

* Completionǣ•–—†‡–‹•‡˜ƒŽ—ƒ–‡†„ƒ•‡†‘…‘’Ž‡–‹‘Ȁ’‡”ˆ‘”ƒ…‡‘ˆ–Š‡–ƒ•

ȗȗCompetency:•–—†‡–‹•‡˜ƒŽ—ƒ–‡†„ƒ•‡†‘Š‹•ȀŠ‡”ƒ„‹Ž‹–›–‘ƒ…Š‹‡˜‡–Š‡‡š’‡…–‡†•–ƒ†ƒ”†

• ‹‹Ǧǣ‹‹Ǧ…Ž‹‹…ƒŽ‡˜ƒŽ—ƒ–‹‘‡š‡”…‹•‡

• ǣƒ•‡Ǧ„ƒ•‡††‹•…—••‹‘

• ǣ˜‹†‡…‡Ǧ„ƒ•‡†’”‡•…”‹’–‹‘

• ǣŽ‡…–”‘…ƒ”†‹‘‰”ƒ

• ǣ”–‡”‹ƒŽ„Ž‘‘†‰ƒ•‡•

• ǣ—Ž‘ƒ”›ˆ—…–‹‘–‡•–

• ǣŠ‡•–šǦ”ƒ›•

• ’”‘Œ‡…–ǣ‡‘—•–Š”‘„‘‡„‘Ž‹•’”‘’Š›Žƒš‹•’”‘Œ‡…–

Appendixes: Evaluation Forms

Form 1:

Clinical Evaluation Exercise (Mini-CEX)

Š‡ Ž‹‹…ƒŽ ˜ƒŽ—ƒ–‹‘ š‡”…‹•‡ ȋ‹‹ǦȌ ƒ••‡••‡• …Ž‹‹…ƒŽ •‹ŽŽ• ȋŠ‹•–‘”› –ƒ‹‰ ‘”

’Š›•‹…ƒŽ ‡šƒ‹ƒ–‹‘Ȍǡ ƒ––‹–—†‡• ƒ† „‡Šƒ˜‹‘”• ‹ ƒ …Ž‹‹…ƒŽ •‡––‹‰Ǥ – ‹• ’ƒ”– ‘ˆ –Š‡

™‘”’Žƒ…‡Ǧ„ƒ•‡†ƒ••‡••‡–…‘’‘‡–‘ˆ–Š‡Ǧ’‘”–ˆ‘Ž‹‘Ǥ

How mini-CEX works

Š‡‹‹Ǧ’”‘˜‹†‡•ƒͳͲǦ–‘ʹͲǦ‹—–‡•ƒ’•Š‘–‘ˆŠ‘™›‘—‹–‡”ƒ…–™‹–Š”‡ƒŽ’ƒ–‹‡–•

‹–Š‡‹’ƒ–‹‡–•ǡ‘—–’ƒ–‹‡–•‘”…ƒ”‡•‡––‹‰•Ǥ‘—ƒ”‡‡š’‡…–‡†–‘’‡”ˆ‘”ƒ–Ž‡ƒ•–‘‡

‹‹Ǧ’‡”…Ž‹‹…ƒŽ”‘–ƒ–‹‘Ǥ

Preparing for mini-CEX

ƒ…Š‹‹Ǧ•Š‘—Ž†”‡’”‡•‡–ƒ…Ž‹‹…ƒŽ’”‘„Ž‡Ǥ‘—•Š‘—Ž†ƒ””ƒ‰‡™‹–Š›‘—”–‡ƒ

•‡‹‘””‡•‹†‡–ȋ͵‘”ͶȌǡ•’‡…‹ƒŽ‹•–ǡ‘”…‘•—Ž–ƒ––Š‡–‹‡ˆ‘”‡˜ƒŽ—ƒ–‹‘Ǥ

Using mini-CEX feedback

Š‡ ƒ••‡••‘” ™‹ŽŽ ‰‹˜‡ ›‘— ƒ ‹‡†‹ƒ–‡ ˆ‡‡†„ƒ… ˜‡”„ƒŽŽ› ƒ† ‹ ™”‹–‹‰Ǥ ‘— ™‹ŽŽ „‡

”‡“—‹”‡†–‘†‡˜‡Ž‘’ƒŽ‡ƒ”‹‰’Žƒ„ƒ•‡†‘–Š‡”‡…‡‹˜‡†ˆ‡‡†„ƒ…Ǥ

After completing mini-CEX

‘—ƒ”‡‡š’‡…–‡†–‘—’Ž‘ƒ†ƒ‹‹—‘ˆ–™‘‹‹Ǧˆ‘”•–‘›‘—”Ǧ’‘”–ˆ‘Ž‹‘„›–Š‡

‡†‘ˆ–Š‡‘†—Ž‡Ǥ

Assessor name: ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴Assessor position: ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴

MED Student: ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴Year ȋ’Ž‡ƒ•‡•…‹”…Ž‡Ȍǣ 4 5 6 Date: ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴ Module: ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴

Patient’s problem/Dxǣ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴

Setting:☐—–’ƒ–‹‡–☐’ƒ–‹‡–☐☐–Š‡”̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴

Complexity:☐‘™☐‘†‡”ƒ–‡☐‹‰Š

Focus: ☐‹•–‘”›☐Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘

expectations ^Below

for year of study

Borderline

for year of study Meets expectations for

year of study

Above expectations for

year of study

Not observed/

Unable to comment

History taking ☐ ☐ ☐ ☐ ☐

Physical examination ☐ ☐ ☐ ☐ ☐

Communication

skills/professionalism

☐

☐

☐

☐

☐

Clinical judgment ☐ ☐ ☐ ☐ ☐

Organization/efficacy ☐ ☐ ☐ ☐ ☐

Overall clinical competence

☐ ☐ ☐ ☐ ☐

›–Š‹‰‡•’‡…‹ƒŽŽ›‰‘‘†ǫ

”‡ƒ•ˆ‘”†‡˜‡Ž‘’‡–ƒ†•’‡…‹ˆ‹…ƒ…–‹‘’‘‹–•ˆ‘”

‹’”‘˜‡‡–ǫ

Assessor name: Student Signature:

Mini-Clinical Evaluation Exercise (CEX)

Form 2:

Case-based Discussion (CBD)

ƒ•‡Ǧ„ƒ•‡†‹•…—••‹‘ȋȌ…‘…‡”•ƒ’ƒ–‹‡–…ƒ•‡ǣ—•‹‰†ƒ–ƒ‹†‡–‹ˆ‹‡†ƒ†”‡…‘”†‡†

by the student on a real patient. It involves a comprehensive review of a patient’s …Ž‹‹…ƒŽ

•‹–—ƒ–‹‘„ƒ•‡†‘ƒ†‹•…—••‹‘„‡–™‡‡–Š‡•–—†‡–ƒ†–Š‡ƒ••‡••‘”ƒ™ƒ›ˆ”‘–Š‡

’ƒ–‹‡–Ǥ–‹•‘–ƒ‹‹’”‡•‡–ƒ–‹‘‘ˆƒ…‘†‹–‹‘‘”‹ŽŽ‡••ǤŠ‡•–—†‡–‹•‰‹˜‡ˆ‡‡†„ƒ…

ˆ”‘–Š‡ƒ••‡••‘”ƒ…”‘••ƒ”ƒ‰‡‘ˆƒ”‡ƒ•”‡Žƒ–‹‰–‘…Ž‹‹…ƒŽ”‡…‘”†‡‡’‹‰ǡ…Ž‹‹…ƒŽ

ƒ••‡••‡–ǡƒƒ‰‡‡–ƒ†…Ž‹‹…ƒŽ”‡ƒ•‘‹‰Ǥ–‹•’ƒ”–‘ˆ–Š‡™‘”’Žƒ…‡Ǧ„ƒ•‡†

ƒ••‡••‡–…‘’‘‡–‘ˆ–Š‡Ǧ’‘”–ˆ‘Ž‹‘Ǥ How CBD works

–ƒ‡•’Žƒ…‡ˆƒ…‡Ǧ–‘Ǧˆƒ…‡‘˜‡”ƒ’’”‘š‹ƒ–‡Ž›͵Ͳ‹—–‡•‹–‘–ƒŽȋʹͲ‹—–‡•ˆ‘”

ƒ†ͳͲ‹—–‡•ˆ‘”…‘•–”—…–‹˜‡ˆ‡‡†„ƒ…ȌǤŠ‡†‹•…—••‹‘™‹ŽŽ…‘˜‡”Š‹•–‘”›–ƒ‹‰ǡ

’Š›•‹…ƒŽ‡šƒ‹ƒ–‹‘ǡƒ†›‘—”†‹ƒ‰‘•–‹…ƒ†ƒƒ‰‡‡–ƒ’’”‘ƒ…ŠǤ‘—ƒ”‡‡š’‡…–‡†–‘

’‡”ˆ‘”‘‡†—”‹‰–Š‡‘†—Ž‡Ǥ

Preparing for CBD

‘—•Š‘—Žd document a patient’s clinical situation in a record mimicking the patient’s

Š‘•’‹–ƒŽ‡†‹…ƒŽ”‡…‘”†ȋƒ–‡’Žƒ–‡™‹ŽŽ„‡’”‘˜‹†‡†ȌǤŠ‡ǡ›‘—•Š‘—Ž†•…Š‡†—Ž‡ƒ

ƒ’’‘‹–‡–ˆ‘”–Š‡™‹–Š›‘—”ƒ••‡••‘”ȋƒˆƒ…—Ž–›‡„‡”Ȍ„‡ˆ‘”‡–Š‡‡†‘ˆ–Š‡

‘†—Ž‡Ǥ

Using CBD feedback

Š‡ƒ••‡••‘”™‹ŽŽ‰‹˜‡›‘—ƒ‹‡†‹ƒ–‡ˆ‡‡†„ƒ…Ǥ‘—™‹ŽŽ„‡”‡“—‹”‡†–‘†‡˜‡Ž‘’ƒ

Ž‡ƒ”‹‰’Žƒ„ƒ•‡†‘–Š‡”‡…‡‹˜‡†ˆ‡‡†„ƒ…Ǥ

After completing CBD

‘—ƒ”‡‡š’‡…–‡†–‘—’Ž‘ƒ†–Š‡‡˜ƒŽ—ƒ–‹‘ˆ‘”–‘›‘—”Ǧ’‘”–ˆ‘Ž‹‘„›–Š‡‡†‘ˆ–Š‡

‘†—Ž‡Ǥ

Assessor name: ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴Assessor position: ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴

MED Student: ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴Year ȋ’Ž‡ƒ•‡•…‹”…Ž‡Ȍǣ 4 5 6 Date: ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴ Module: ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴

Patient’s problem/Dxǣ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴

Setting:☐—–’ƒ–‹‡–☐’ƒ–‹‡–☐☐–Š‡”̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴

Complexity:☐‘™☐‘†‡”ƒ–‡☐‹‰Š

^Below expectations

for year of study

Borderline for year of study

Meets expectations for year of study on

Above expectations for year of study

Not observed/

Unable to comment

Documentation ☐ ☐ ☐ ☐ ☐

Case presentation skills ☐ ☐ ☐ ☐ ☐

Diagnostic approach

▪ ”‘„Ž‡Ž‹•–

▪ ‹ˆˆ‡”‡–‹ƒŽ†‹ƒ‰‘•‡•Ž‹•–

▪ ‹–‹ƒŽ‹˜‡•–‹‰ƒ–‹‘•

☐

☐

☐

☐

☐

☐

☐

☐

☐

☐

☐

☐

☐

☐

☐

Management plan ☐ ☐ ☐ ☐ ☐

Organization/efficacy ☐ ☐ ☐ ☐ ☐

Overall clinical competence ☐ ☐ ☐ ☐ ☐

›–Š‹‰‡•’‡…‹ƒŽŽ›‰‘‘†ǫ

”‡ƒ•ˆ‘”†‡˜‡Ž‘’‡–ƒ†•’‡…‹ˆ‹…ƒ…–‹‘’‘‹–•ˆ‘”

‹’”‘˜‡‡–ǫ

Assessor name: Student Signature:

Case-based Discussion (CBD)

Form 3:

Name:

University #:

1. ECG reading

‘’‡–‡…›ȗ ☐‡•☐‘ ☐‡•☐‘ ☐‡•☐‘

—’‡”˜‹•‘”ƒ‡

ƒ–‡

*Students show competent understanding in data interpretation 2. Arterial blood gases ABG interpretation

‘’‡–‡…›ȗ ☐‡•☐‘ ☐‡•☐‘

—’‡”˜‹•‘”ƒ‡

ƒ–‡

*Students show competent understanding in data interpretation 3. Pulmonary function test interpretation

‹ƒ‰‘•‹•

—’‡”˜‹•‘”ƒ‡

ƒ–‡

4. Pleural fluid analysis

‹ƒ‰‘•‹•

—’‡”˜‹•‘”ƒ‡

ƒ–‡

5. Chest x-ray reading

‘’‡–‡…›ȗ ☐‡•☐‘ ☐‡•☐‘ ☐‡•☐‘ ☐‡•☐‘

—’‡”˜‹•‘”ƒ‡

ƒ–‡

*Students show competent understanding in data interpretation 6. Radiology Department Visit

—’‡”˜‹•‘”ƒ‡

ƒ–‡

‡˜‹‡™‡†…ƒ•‡•ǣ ͳǤ ʹǤ

͵Ǥ ͶǤ ͷǤ

͸Ǥ

Module B Data Interpretation Card

Form 4:

Evidence-Based Practice (EBP)

R X

^EEducational Prescription ^{vidence-Based Practice (EBP)} Ward:

Hospital: Learner names:

Learner’s ID:

4-part Clinical Question (PICO) Target disorder: (patient or population or problem)

Intervention: (new alternative – drug, physiotherapy, surgery, radiotherapy, procedure)

Comparison (+/-): (old or standard treatment or surgical procedure, etc)

Outcome: (What you are interested in? such as survival, symptoms reduction, quality of life, reduced sick-listed time, side effect, relapses, etc)

Summary: Summary and presentation cover:

• Search strategy brief

• Quotation of the evidence or Guideline

• Level of the evidence and strength of recommendation

• Impact of evidence or its outcome

• Can it be applied to your patient? What is your opinion?

Overall performance:

☐ Satisfactory ☐Not satisfactory Tutor’s feedback:

Tutor name: Tutor signature:

Form 5:

Year 4 Procedures Card

Form 6:

Venous Thromboembolism (VTE) project

‡‘—• –Š”‘„‘‡„‘Ž‹• ȋȌ ’”‘Œ‡…– ƒ‹• –‘ ”ƒ•‹‡ –Š‡ ‡†‹…ƒŽ •–—†‡–• ƒ™ƒ”‡••

ƒ„‘—––Š‡‹’ƒ…–‘ˆ‘Š‘•’‹–ƒŽ‹œ‡†’ƒ–‹‡–•ƒ†–Š‡Š‹‰Š‘”–ƒŽ‹–›Ǥ–™‹ŽŽ„‡ƒ’ƒ”–‘ˆ

–Š‡™‘”’Žƒ…‡Ǧ„ƒ•‡†ƒ••‡••‡–…‘’‘‡–‘ˆ–Š‡Ǧ’‘”–ˆ‘Ž‹‘Ǥ

How VTE project works

’”‘Œ‡…– involves a comprehensive review of a patient’s clinical situation ƒ†

ƒ••‡••‡–‘ˆŠ‹•ȀŠ‡””‹•ˆƒ…–‘”•ˆ‘”ƒ•™‡ŽŽƒ•–Š‡”‹••‘ˆ„Ž‡‡†‹‰ǤŠ‡„ƒ•‡†‘

the patient’s VTE risk, ƒ†‡…‹•‹‘•Š‘—Ž†„‡ƒ†‡ƒ„‘—––Š‡ƒ’’”‘’”‹ƒ–‡’”‘’Š›Žƒš‹•Ǥ

Using VTE project feedback

Š‡ ‡†—…ƒ–‹‘ƒŽ •—’‡”˜‹•‘” ™‹ŽŽ ‰‹˜‡ ›‘— ƒ ‹‡†‹ƒ–‡ ˆ‡‡†„ƒ… †—”‹‰ ‘†—Ž‡ •‹‰Ǧ‘ˆˆ

‡‡–‹‰Ǥ‘—Šƒ˜‡–‘†‡˜‡Ž‘’ƒŽ‡ƒ”‹‰’Žƒ„ƒ•‡†‘–Š‡”‡…‡‹˜‡†ˆ‡‡†„ƒ…Ǥ

After completing VTE project

‘— ƒ”‡ ‡š’‡…–‡† –‘ —’Ž‘ƒ† –Š‡ ˆ‘” –‘ ›‘—” Ǧ’‘”–ˆ‘Ž‹‘ „› –Š‡ ‡† ‘ˆ ‡ƒ…Š Š‘”‹œ‘–ƒŽ

‘†—Ž‡Ǥ

Student Name: Module

Gender : ☐Male ☐Female

Venue:  ‘•’‹–ƒŽ™ƒ”†

 —–’ƒ–‹‡–…Ž‹‹…

 Other ………

Age: Date studied:

Diagnosis:

Medical history, including. drug history, personal and family history of previous VTE:

Current treatment episode:

Risk assessment 1. –ƒ–‡”‹•ˆƒ…–‘”•ǣ

2. –ƒ–‡”‹••‘ˆ„Ž‡‡†‹‰ǣ

3. Šƒ–do you consider to be the patient’s risk of VTE?

ȋ‘™‘”Š‹‰Š”‹•Ȍƒ†™Š›ǫ

”‡•…”‹„‡†’”‘’Š›Žƒš‹•”‡‰‹‡™‹–Š

†ƒ–‡•ȋ…‘•‹†‡”„‘–Š’Šƒ”ƒ…‘Ž‘‰‹…ƒŽƒ†

‡…Šƒ‹…ƒŽȌ

ƒ•–Š‡’”‡•…”‹„‡†’”‘’Š›Žƒš‹•ˆ‘”

–Š‹•’ƒ–‹‡–ƒ’’”‘’”‹ƒ–‡ǫȀIf not, what would you have done differently?

ƒ˜‡ƒ›†‘•‡•„‡‡‹••‡†ǫȀˆ

›‡•ǡ‡š’Žƒ‹Ǥ

Case discussed with: Consultant Other clinician Pharmacist

Assessor name: Student Signature:

Assessor Signature: Date:

Date:

ȗEach project must be signed off by your educational supervisor.

Venous Thromboembolism (VTE) project